var title_f15_28_15808="Tubal ring with piston grip";
var content_f15_28_15808=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F68822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F68822&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Fallopian tube ring applicator showing piston grip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 245px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15808=[""].join("\n");
var outline_f15_28_15808=null;
var title_f15_28_15809="Bronchoscopy forceps";
var content_f15_28_15809=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50208&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Bronchoscopy forceps",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 303px; height: 253px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Bronchoscopic biopsy forceps with jaws open.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15809=[""].join("\n");
var outline_f15_28_15809=null;
var title_f15_28_15810="Cocaine purpura";
var content_f15_28_15810=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F74436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F74436&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Purpura due to cocaine adulterated with levamisole",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Retiform purpura are present on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15810=[""].join("\n");
var outline_f15_28_15810=null;
var title_f15_28_15811="Serous cystadenoma PAS Light";
var content_f15_28_15811=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F71673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F71673&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Pancreatic serous cystadenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 377px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Periodic Acid Schiff (PAS) staining of pancreatic serous cystadenoma. Note positive staining identifying glycogen-rich cells lining cystic spaces.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mike Steer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15811=[""].join("\n");
var outline_f15_28_15811=null;
var title_f15_28_15812="Fidaxomicin: Drug information";
var content_f15_28_15812=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fidaxomicin: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?32/53/33619?source=see_link\">",
"    see \"Fidaxomicin: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F13120424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Dificid&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F14732997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dificid&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F12861920\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Macrolide",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F12923821\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Treatment of diarrhea due to",
"     </b>",
"     <b>",
"      <i>",
"       Clostridium difficile",
"      </i>",
"     </b>",
"     <b>",
"      (CDAD):",
"     </b>",
"     Oral: 200 mg twice daily for 10 days",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F12923822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F12923834\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Minimal systemic absorption; no dosage adjustment needed",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F12923835\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not studied; minimally absorbed, so no dosage adjustment predicted",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F13120425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dificid&trade;: 200 mg [contains soy lecithin]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F12923550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F12923824\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be administered with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F12861917\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of",
"     <i>",
"      Clostridium difficile",
"     </i>",
"     -associated diarrhea (CDAD)",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F12923734\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Gastrointestinal: Nausea (11%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     2% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Gastrointestinal hemorrhage (4%), abdominal pain, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Anemia (2%), neutropenia (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;2%: Abdominal distension, abdominal tenderness, alkaline phosphatase increased, blood bicarbonate decreased, drug eruption, dyspepsia, dysphagia, flatulence, hepatic enzymes increased, hyperglycemia, intestinal obstruction, megacolon, metabolic acidosis, platelet count decreased, pruritus, rash",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F12923669\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     There are no contraindications listed in the manufacturer's labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F12923670\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use: Do not use for systemic infections; fidaxomicin systemic absorption is negligible. Use only in patients with proven or strongly suspected",
"     <i>",
"      Clostridium difficile (C. difficile)",
"     </i>",
"     infections.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299334\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F12931805\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F12923666\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F12923667\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adverse events were not observed in animal reproduction studies. Due to the limited oral absorption of fidaxomicin, exposure to the fetus is expected to be low. There are no adequate and well-controlled studies in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F12923668\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F16355080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     It is not known if fidaxomicin is excreted in breast milk. The manufacturer recommends that caution be exercised when administering fidaxomicin to nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F12923823\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     May be taken without regard to food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16322903\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Dificid Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     200 mg (20): $3549.30",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F12923775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits RNA polymerase sigma subunit resulting in inhibition of protein synthesis and cell death in susceptible organisms including",
"     <i>",
"      C. difficile",
"     </i>",
"     ; bactericidal",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F12923777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Oral: Minimal systemic absorption",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: Largely confined to the gastrointestinal tract; in single- and multiple-dose studies, fecal concentrations of fidaxomicin and its active metabolite (OP-1118) are very high while serum concentrations are minimally detectable to undetectable",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Intestinal hydrolysis to less active metabolite (OP-1118)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Feces (&gt;92% as unchanged drug and metabolites); urine (&lt;1% as metabolite)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Cohen SH, Gerding DN, Johnson S, et al, \"Clinical Practice Guidelines for",
"      <i>",
"       Clostridium difficile",
"      </i>",
"      Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA),\"",
"      <i>",
"       Infect Control Hosp Epidemiol",
"      </i>",
"      , 2010, 31(5):431-55.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/20307191/pubmed\" id=\"20307191\" target=\"_blank\">",
"        20307191",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Louie TJ, Emery J, Krulicki W, et al, \"OPT-80 Eliminates",
"      <i>",
"       Clostridium difficile",
"      </i>",
"      and Is Sparing of Bacteroides Species During Treatment of",
"      <i>",
"       C. difficile",
"      </i>",
"      Infection,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2009, 53(1):261-3.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/18955523/pubmed\" id=\"18955523\" target=\"_blank\">",
"        18955523",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Louie TJ, Miller MA, Mullane KM, et al, \"Fidaxomicin Versus Vancomycin for",
"      <i>",
"       Clostridium difficile",
"      </i>",
"      Infection,\"",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2011, 364(5):422-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/21288078/pubmed\" id=\"21288078\" target=\"_blank\">",
"        21288078",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Louie T, Miller M, Donskey C, et al, \"Clinical Outcomes, Safety, and Pharmacokinetics of OPT-80 in a Phase 2 Trial With Patients With",
"      <i>",
"       Clostridium difficile",
"      </i>",
"      Infection,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2009, 53(1):223-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/18955525/pubmed\" id=\"18955525\" target=\"_blank\">",
"        18955525",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Shue YK, Sears PS, Shangle S, et al, \"Safety, Tolerance, and Pharmacokinetic Studies of OPT-80 in Healthy Volunteers Following Single and Multiple Oral Doses,\"",
"      <i>",
"       Antimicrob Agents Chemother",
"      </i>",
"      , 2008, 52(4):1391-5.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/18268081/pubmed\" id=\"18268081\" target=\"_blank\">",
"        18268081",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Sullivan KM and Spooner LM, \"Fidaxomicin: A Macrocyclic Antibiotic for the Management of",
"      <i>",
"       Clostridium difficile",
"      </i>",
"      Infection,\"",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2010, 44(2):352-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/20071495/pubmed\" id=\"20071495\" target=\"_blank\">",
"        20071495",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Tannock GW, Munro K, Taylor C, et al, \"A New Macrocyclic Antibiotic, Fidaxomicin (OPT-80), Causes Less Alteration to the Bowel Microbiota of",
"      <i>",
"       Clostridium difficile",
"      </i>",
"      -Infected Patients Than Does Vancomycin,\"",
"      <i>",
"       Microbiology",
"      </i>",
"      , 2010, 156(Pt 11):3354-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?15/28/15812/abstract-text/20724385/pubmed\" id=\"20724385\" target=\"_blank\">",
"        20724385",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 16497 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-A7B94B43F3-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15812=[""].join("\n");
var outline_f15_28_15812=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13120424\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14732997\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12861920\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923821\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923822\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923834\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923835\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13120425\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923550\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923824\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12861917\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923734\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923669\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923670\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299334\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12931805\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923666\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923667\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923668\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16355080\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923823\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16322903\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923775\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F12923777\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16497\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/16497|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?32/53/33619?source=related_link\">",
"      Fidaxomicin: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_28_15813="Clonidine and chlorthalidone: Patient drug information";
var content_f15_28_15813=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Clonidine and chlorthalidone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/21/15702?source=see_link\">",
"     see \"Clonidine and chlorthalidone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F153568\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Clorpres&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10078683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015075\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701842",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to clonidine, chlorthalidone, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703827",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have very bad kidney disease.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015079\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697204",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), talk with your doctor. This drug may raise blood sugar.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015080\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium levels like muscle pain or weakness, muscle cramps, or a heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015082\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015077\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015078\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015083\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015084\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12303 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.167.4.114-B6D75EF485-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15813=[""].join("\n");
var outline_f15_28_15813=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F153568\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10078683\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015075\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015074\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015079\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015080\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015082\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015077\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015078\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015083\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015084\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/21/15702?source=related_link\">",
"      Clonidine and chlorthalidone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_28_15814="Basic shoulder anatomy anterior view";
var content_f15_28_15814=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F72709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F72709&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 620px\">",
"   <div class=\"ttl\">",
"    Anterior view of shoulder anatomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 600px; height: 436px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15814=[""].join("\n");
var outline_f15_28_15814=null;
var title_f15_28_15815="Field care and evaluation of the young athlete with acute neck injury";
var content_f15_28_15815=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Field care and evaluation of the young athlete with acute neck injury",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Jason E Decker, MD, FAAP",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Albert C Hergenroeder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Joseph Chorley, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Richard G Bachur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15815/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15815/contributors\">",
"     James F Wiley, II, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/28/15815/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 8, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute trauma to the neck of a young athlete may injure the cervical spine, the neck vessels, and the aerodigestive tract. Because of the vital importance of these structures, athletes with acute complaints of neck pain or injury must be thoroughly evaluated so that appropriate management and referral decisions can be made, and preventable catastrophic injuries can be avoided.",
"   </p>",
"   <p>",
"    Every patient with an acute neck injury must be assumed to have a serious spinal cord injury until proven otherwise. Failure to adhere to this dictum can result in catastrophic, permanent cervical spine injury [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/1\">",
"     1",
"    </a>",
"    ]. Prehospital personnel who treat patients with potential cervical spine injuries have three priorities:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      To ensure patient survival",
"     </li>",
"     <li>",
"      To preserve residual spinal cord function",
"     </li>",
"     <li>",
"      To transport the patient safely to a medical center so that definitive evaluation and treatment can be initiated",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Primary neurologic injury is sustained at the time of impact, and is treated at a medical care facility under the direction of appropriate specialists [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/1\">",
"     1",
"    </a>",
"    ]. Secondary neurologic injury results from a biochemical cascade of events such as hemorrhage, release of vasoactive amines, and edema. Prevention of secondary injury is the primary goal of prehospital and hospital care of the young athlete with acute neck injury.",
"   </p>",
"   <p>",
"    The prehospital care and evaluation of young athletes with acute neck injuries include the following steps [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Preparation",
"     </li>",
"     <li>",
"      Suspicion and recognition",
"     </li>",
"     <li>",
"      Stabilization and safety",
"     </li>",
"     <li>",
"      Immediate treatment and possible secondary treatment",
"     </li>",
"     <li>",
"      Evaluation for return to play.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The prehospital evaluation and initial management of the young athlete with an acute neck injury will be discussed here. The approach to the athlete with a complaint of neck pain or injury and overviews of musculoskeletal, cervical spinal cord, and cervical peripheral nerve injuries are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41368?source=see_link\">",
"     \"Approach to the young athlete with neck pain or injury\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11033?source=see_link\">",
"     \"Overview of musculoskeletal neck injuries in the young athlete\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23689?source=see_link\">",
"     \"Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe neck injuries with permanent neurologic sequelae occur rarely among young athletes. Because these injuries are uncommon, most youth team physicians and trainers have little experience managing them [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/3\">",
"     3",
"    </a>",
"    ]. Nonetheless, the management of athletes with potential cervical spine injuries must be a well-coordinated process.",
"   </p>",
"   <p>",
"    Personnel involved in youth team sports, particularly the team physician, must be prepared for the possibility of a cervical spine injury [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/4\">",
"     4",
"    </a>",
"    ]. Adequate preparation and familiarity with individual roles and duties are of paramount importance in avoiding preventable catastrophic injuries [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/3,5\">",
"     3,5",
"    </a>",
"    ]. Preseason rehearsal of the acute care of the injured athlete can help prevent the stress and confusion that may arise when a severe injury occurs without such rehearsal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arrangements should be made to have an ambulance at the athletic event (particularly football games) or readily available in case an athlete requires urgent transport to a medical facility [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/5\">",
"     5",
"    </a>",
"    ]. In addition, all necessary equipment should be on hand and easily accessible. Necessary equipment includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A bag-valve-mask for ventilation (with various mask sizes depending upon the",
"      <span class=\"nowrap\">",
"       age/size",
"      </span>",
"      of the participating athletes)",
"     </li>",
"     <li>",
"      Equipment to safely remove protective gear (eg, face mask in football)",
"     </li>",
"     <li>",
"      Immobilization devices (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"       \"Pediatric cervical spine immobilization\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      A backboard",
"     </li>",
"     <li>",
"      A mobile phone to contact Emergency Medical Services (EMS)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SUSPICION AND RECOGNITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The field medical personnel should watch the sporting event carefully so that, if at all possible, they can directly witness the mechanism of injury. Every athlete with an acute neck injury must be assumed to have a serious spinal cord injury until proven otherwise. This is particularly applicable in the case of an athlete who has lost consciousness, since the symptoms and signs of cervical injury may be less obvious than in the awake athlete, who can complain of cervical muscle spasm or pain. However, even in the conscious athlete, cervical spine injuries may or may not have observable neurologic findings, and a high index of suspicion must be maintained [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/6\">",
"     6",
"    </a>",
"    ]. Because cervical spine injuries can progress, not all significant injuries may be recognized immediately. Suspicion and recognition of cervical spine injuries in the athlete who is able to walk from the field are discussed below. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Cervical spine evaluation in the ambulatory athlete'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     STABILIZATION AND SAFETY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The necks of patients in whom cervical spine injuries are suspected must not be manipulated [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/7\">",
"     7",
"    </a>",
"    ]. No attempt should be made to move the athlete except as necessary to provide cardiopulmonary resuscitation (CPR) or transportation to a medical facility.",
"   </p>",
"   <p>",
"    Before resuscitation or transport, the cervical spine must be immobilized; immobilization must be maintained until cervical spine injury is ruled out clinically or radiographically [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/8\">",
"     8",
"    </a>",
"    ]. An estimated 3 to 25 percent of patients with spinal cord injury develop neurologic deficits as a result of manipulation during resuscitation or transport [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/9-11\">",
"     9-11",
"    </a>",
"    ]. Extension of cervical cord injury can be avoided with proper immobilization and careful airway management [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/12\">",
"     12",
"    </a>",
"    ]. Cervical spine immobilization is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"     \"Pediatric cervical spine immobilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Immobilization",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first step in cervical spine immobilization is immobilization of the neck by holding the head and neck in a neutral position [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/5\">",
"     5",
"    </a>",
"    ]. Care must be taken in the immobilization of an obviously deviated cervical spine. The Advanced Trauma Life Support (ATLS) program recommends that \"no effort be made to reduce an obvious deformity, especially in children. Instead, maintain the patient in a neutral position\" [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/13\">",
"     13",
"    </a>",
"    ]. Patients who are found in the prone position must be log-rolled to the supine position for further evaluation and management. The log-roll maneuver is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"     \"Pediatric cervical spine immobilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Helmet removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether to maintain the helmet in place or remove it varies by whether shoulder pads are also worn as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Helmet with shoulder pads",
"      </strong>",
"      &ndash; The American College of Sports Medicine (ACSM) strongly recommends",
"      <strong>",
"       NOT",
"      </strong>",
"      to remove an American football helmet and shoulder pads from an unconscious athlete or an athlete who has sustained a neck injury [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/14\">",
"       14",
"      </a>",
"      ]. Proper immobilization of the spine and safe transportation to the hospital can be accomplished without removal; football helmet padding prevents head movement within the shell. As a general rule, the helmet and the chin strap should be left in place, and the face mask should be removed to aid in the assessment and maintenance of airway and breathing [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/15\">",
"       15",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Because the shoulder pads in football elevate the player's shoulders in the supine position, removal of the helmet causes the head to drop out of the neutral, midline position. In addition, if the shoulder pads are removed but the helmet is not, the neck will be forced into flexion. Thus, the shoulder pads should",
"      <strong>",
"       not",
"      </strong>",
"      be removed if the helmet remains in place. This approach also applies to ice hockey and lacrosse players as long as the shoulder pads with helmet maintain the athlete&rsquo;s cervical spine in neutral position.",
"      <br/>",
"      <br/>",
"      When it is necessary to gain access to the athlete's face for cardiopulmonary resuscitation, airway management, or other reasons, the ACSM advises that only the face mask and chin strap be removed and the helmet left in place. A number of specifically designed tools can be used to remove the plastic bars that secure the face mask to the helmet [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/16\">",
"       16",
"      </a>",
"      ]. If no such tool is available, heavy duty trauma shears can be used.",
"      <br/>",
"      <br/>",
"      To further minimize head motion, towel rolls, foam head blocks, and tape may be used.",
"      <br/>",
"      <br/>",
"      Despite the general recommendation to keep football helmets in place, there are certain circumstances in which the helmet should be removed [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/2,6\">",
"       2,6",
"      </a>",
"      ], including:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      If immobilization of the helmet does not immobilize the head (ie, if the helmet and chin strap do not hold the head securely)",
"     </li>",
"     <li>",
"      If, even after removal of the face mask, the airway cannot be controlled, nor ventilation provided",
"     </li>",
"     <li>",
"      If the face mask cannot be removed",
"     </li>",
"     <li>",
"      If the helmet prevents immobilization in an appropriate position for transport.",
"      <br/>",
"      <br/>",
"      If helmet removal is necessary, it should be performed in a controlled manner. One person should stabilize the head, neck, and helmet, while a second person cuts the chin strap. Before removal of the helmet, accessible internal padding should be removed and air padding should be deflated. During this process, the chin and back of the neck must be manually stabilized and maintained in the neutral position [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/17\">",
"       17",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      When it is necessary to remove the helmet, the shoulder pads should be removed as well [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/18\">",
"       18",
"      </a>",
"      ]. Shoulder pads also should be removed when multiple injuries require full access to the shoulder area, or when poorly fitting shoulder pads prevent proper spinal immobilization [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/6\">",
"       6",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Helmets without shoulder pads",
"      </strong>",
"      &ndash; Helmets that are worn without shoulder pads (eg, batting helmets, bike helmets, motorcycle helmets) should be removed to permit immobilization of the cervical spine in the neutral position. Failure to maintain a neutral position could result in serious damage to the cervical spinal cord in an athlete with an unstable cervical spine injury. Thus, when necessary, helmet removal should be performed by a health-care provider who has experience and expertise in helmet removal.",
"      <br/>",
"      <br/>",
"      When the athlete is clinically stable (eg, clear airway with normal breathing and circulation), waiting for EMS to arrive is better than attempted helmet removal by an inexperienced person. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"       \"Pediatric cervical spine immobilization\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      The proper removal of a motorcycle helmet is discussed in more detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31274?source=see_link&amp;anchor=H5#H5\">",
"       \"Evaluation and acute management of cervical spinal column injuries in adults\", section on 'Helmet removal'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     IMMEDIATE TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Once the cervical spine is immobilized, the initial evaluation of the athlete with acute neck injury should begin with an assessment of the patient's airway, breathing, and circulation (",
"    <a class=\"graphic graphic_algorithm graphicRef80228 \" href=\"UTD.htm?8/62/9184\">",
"     algorithm 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Airway and breathing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Blunt trauma to the anterior neck, particularly when the neck is extended, can result in crush injury to the trachea and larynx. A direct blow to the neck also may precipitate acute laryngospasm.",
"   </p>",
"   <p>",
"    Symptoms of airway compromise, such as stridor and respiratory distress, may occur immediately following the injury if the airway diameter is significantly reduced. On the other hand, if the airway is not acutely collapsed, the symptoms may be delayed until the onset of edema, which occurs several hours after the injury.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the athlete is breathing, the mouth guard should be removed and the airway maintained [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Athletes who are not breathing spontaneously must have an airway established and ventilation initiated. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=see_link\">",
"       \"Basic airway management in children\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=see_link\">",
"       \"Emergent endotracheal intubation in children\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In athletes who have significant airway obstruction, the jaw-thrust maneuver can be used to maintain airway patency. Care should be taken to avoid excess spinal movement (",
"      <a class=\"graphic graphic_figure graphicRef53277 \" href=\"UTD.htm?42/28/43470\">",
"       figure 1",
"      </a>",
"      ). If the jaw thrust maneuver fails to achieve adequate air exchange, an artificial airway must be obtained. Any patient with significant airway trauma should be transported quickly to a hospital for definitive management. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link&amp;anchor=H9#H9\">",
"       \"Pediatric cervical spine immobilization\", section on 'Airway management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Acute laryngospasm may resolve spontaneously with relaxation and supplemental oxygen.",
"     </li>",
"     <li>",
"      Athletes with acute neck injuries who have patent airways and are breathing spontaneously should undergo evaluation of their cervical spine (discussed below). The application of ice may help to reduce post-injury edema, which could lead to airway compromise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Circulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the athlete lacks a pulse, chest compressions should be initiated. Shoulder pads may be opened as necessary to provide access for CPR",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    defibrillation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7864?source=see_link\">",
"     \"Basic life support in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Vascular injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Trauma to the anterior neck can result in injury to the jugular venous system or the carotid and vertebral arteries. These vessels are most often injured in penetrating or high-velocity trauma to the head and neck. Such injuries are uncommon in sports, but when they occur, can be dramatic and life-threatening. In addition to laceration or rupture of these vessels in high-impact trauma, vessel dissection or thrombotic phenomena can occur as a result of intimal injury after seemingly mild trauma or forceful stretching of the neck [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vascular injuries of the neck can be difficult to diagnose, which may result in delay of definitive treatment. Thus, a high index of suspicion for such injuries must be maintained in athletes who sustain neck trauma during competition, particularly if there is severe bleeding from a penetrating neck wound. Direct pressure should be applied and emergent transfer to an appropriate medical facility should be expedited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     CERVICAL SPINE EVALUATION IN THE AMBULATORY ATHLETE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taking a detailed sideline history and performing a vigilant physical examination are critical in the evaluation of the ambulatory athlete who has sustained an acute neck injury and complains of neck pain. The history should include the mechanism of injury; the presence of pain, stiffness, or any neurologic symptoms (including transient ones); and any previous history of neck injuries. Signs and symptoms of cervical spine injury are listed in Table 1 (",
"    <a class=\"graphic graphic_table graphicRef76379 \" href=\"UTD.htm?20/20/20811\">",
"     table 1",
"    </a>",
"    ). Cervical immobilization and transportation should be initiated for athletes who have neurologic symptoms (transient or persistent) suggestive of spinal cord injury.",
"   </p>",
"   <p>",
"    The field examination of an athlete with a possible neck injury should include the following components, performed in the order listed below [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/5\">",
"     5",
"    </a>",
"    ]. If any signs of cervical spine injury are detected, the examination should be discontinued and immobilization and transportation initiated. The examination of the young athlete with acute neck pain or injury is discussed in detail separately. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Stabilization and safety'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41368?source=see_link\">",
"     \"Approach to the young athlete with neck pain or injury\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Mental status examination",
"     </li>",
"     <li>",
"      Motor and sensory testing",
"     </li>",
"     <li>",
"      Neck palpation for cervical tenderness or spasm",
"     </li>",
"     <li>",
"      Gentle, resisted neck isometric contractions in the full range of motion",
"     </li>",
"     <li>",
"      Active range of cervical motion (",
"      <strong>",
"       never",
"      </strong>",
"      perform passive range of motion)",
"     </li>",
"     <li>",
"      Repeat evaluation of cervical motion in the sitting or standing position (if originally performed with the athlete in the supine position)",
"     </li>",
"     <li>",
"      Axial compression and Spurling test for peripheral nerve impingement (",
"      <a class=\"graphic graphic_picture graphicRef52401 \" href=\"UTD.htm?11/45/11999\">",
"       picture 1",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because cervical spine injuries may evolve with time, the initial clinical picture may be deceptive, particularly in athletes who are ambulatory [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/3,20\">",
"     3,20",
"    </a>",
"    ]. If the examining physician is unsure of the nature of the injury, he or she can keep the athlete out of competition and reevaluate. It is always safer to err on the side of caution because of the potential for catastrophic harm to the unstable cervical spine.",
"   </p>",
"   <p>",
"    Signs and symptoms of spinal cord injury include neck pain, numbness, dysesthetic pain, weakness, limited range of motion, paralysis, and loss of consciousness (",
"    <a class=\"graphic graphic_table graphicRef76379 \" href=\"UTD.htm?20/20/20811\">",
"     table 1",
"    </a>",
"    ). Athletes with these findings should have their cervical spines immobilized and be transported for further evaluation. Although it is unusual for an injured athlete who was initially evaluated on the sideline to require full immobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/21\">",
"     21",
"    </a>",
"    ], it should be noted that a cervical collar alone does not adequately protect the cervical spine if the athlete has an unstable cervical fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/21\">",
"     21",
"    </a>",
"    ]. Thus, it is best to treat all neck injuries in which the clinical picture is not clear with full immobilization [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/22\">",
"     22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"     \"Pediatric cervical spine immobilization\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SECONDARY TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Secondary neurologic injury results from a biochemical cascade of events such as hemorrhage, release of vasoactive amines, and edema [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/1\">",
"     1",
"    </a>",
"    ]. Prevention of secondary injury is the primary goal of prehospital and hospital care of the young athlete with acute neck injury.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Methylprednisolone",
"    </span>",
"    &nbsp;&mdash;&nbsp;The use of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?16/63/17401?source=see_link\">",
"     methylprednisolone",
"    </a>",
"    in patients with spinal cord injury is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26810?source=see_link&amp;anchor=H21#H21\">",
"     \"Acute traumatic spinal cord injury\", section on 'Glucocorticoids'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     RETURN TO PLAY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The athlete who is not transported may return to play when he or she is symptom-free and has a normal examination [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/21,23\">",
"     21,23",
"    </a>",
"    ]. Specifically, the patient should have no neck or extremity pain, no motor or sensory deficits or symptoms, no neck tightness or spasm, and full, pain-free range of cervical motion (actively and against hand resistance). The performance of a sport-specific functional sideline examination may be helpful in this assessment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15815/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although standardized guidelines for sport-specific sideline examinations have not been published, the authors recommend the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For football: Two 40-yard sideline sprints, two 40-yard zig-zag sprints, and blocking drills with a teammate. Reevaluate for neurologic symptoms and repeat physical examination.",
"     </li>",
"     <li>",
"      For hockey: Two sprints half the length of the ice, two zig-zags half the length of the ice, brief shooting",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      blocking drills with a teammate (if possible, this evaluation should be performed during stoppage of play, or on ice other than that being played on). Reevaluate for neurologic symptoms and repeat physical examination.",
"     </li>",
"     <li>",
"      For gymnastics: The evaluation depends upon the event (eg, bars, floor, beam, vault, etc); the gymnast should be able to perform short, limited routines or portions of a routine at less than full speed with minimal difficulty. Reevaluate for neurologic symptoms and repeat physical examination.",
"     </li>",
"     <li>",
"      For wrestling: Brief warmup (jogging, push-ups, etc) followed by brief, light sparring with a teammate. Reevaluate for neurologic symptoms and repeat physical examination.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Every patient with an acute neck injury must be assumed to have a serious spinal cord injury until proven otherwise. The neck of a patient in whom a cervical spine injury is suspected must not be manipulated. No attempt should be made to move the athlete except as necessary to provide cardiopulmonary resuscitation (CPR) or transportation to a medical facility. Before resuscitation or transport, the cervical spine must be immobilized (",
"      <a class=\"graphic graphic_algorithm graphicRef80228 \" href=\"UTD.htm?8/62/9184\">",
"       algorithm 1",
"      </a>",
"      ); immobilization must be maintained until cervical spine injury is ruled out clinically or radiographically. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Suspicion and recognition'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=see_link\">",
"       \"Pediatric cervical spine immobilization\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=see_link\">",
"       \"Evaluation of cervical spine injuries in children and adolescents\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      During immobilization, the neck must be in a neutral position. As a general rule, athletes who are wearing a helmet and shoulder pads (eg, American football, ice hockey, and lacrosse players) should not undergo helmet removal because the shoulder pads worn in these sports elevate the shoulders adequately to maintain the neutral position. The face mask of such helmets must be removed to permit access to the airway. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Helmet removal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Helmets that are worn without shoulder pads (eg, batting helmets, bike helmets, motorcycle helmets) should be removed to permit immobilization of the cervical spine in the neutral position. When helmet removal is necessary, it should be performed by a health-care provider who has experience and expertise in helmet removal. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Helmet removal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Once adequate airway, breathing, and circulation have been established, the athlete should be examined for symptoms and signs of cervical spine injury. Signs and symptoms of spinal cord injury include neck pain, numbness, dysesthetic pain, weakness, limited range of motion, paralysis, and loss of consciousness (",
"      <a class=\"graphic graphic_table graphicRef76379 \" href=\"UTD.htm?20/20/20811\">",
"       table 1",
"      </a>",
"      ). An athlete with these findings should have his or her cervical spine immobilized (if not previously immobilized) and be transported for further evaluation. A cervical collar alone does not adequately protect the cervical spine if the athlete has an unstable cervical fracture. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Cervical spine evaluation in the ambulatory athlete'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Because cervical spine injuries may evolve with time, the initial clinical picture may be deceptive, particularly in an athlete who is ambulatory. If the examining physician is unsure of the nature of the injury, he or she can keep the athlete out of competition and reevaluate. It is always safer to err on the side of caution because of the potential for catastrophic harm to the unstable cervical spine. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Return to play'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/1\">",
"      Warren WL Jr, Bailes JE. On the field evaluation of athletic neck injury. Clin Sports Med 1998; 17:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/2\">",
"      Ghiselli G, Schaadt G, McAllister DR. On-the-field evaluation of an athlete with a head or neck injury. Clin Sports Med 2003; 22:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/3\">",
"      Torg JS. Management guidelines for athletic injuries to the cervical spine. Clin Sports Med 1987; 6:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/4\">",
"      Vegso JJ, Lehman RC. Field evaluation and management of head and neck injuries. Clin Sports Med 1987; 6:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/5\">",
"      Haight RR, Shiple BJ. Sideline evaluation of neck pain: when is it time for transport? Phys Sportsmed 2001; 29:45.",
"     </a>",
"    </li>",
"    <li>",
"     Kleiner DM, Almquist JL, Bailes MD, et al. Prehospital care of the spine-injured athlete: a document from the inter-association task force for the appropriate care of the spine-injured athlete. National Athletic Trainers Association, Dallas, TX 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/7\">",
"      Proctor MR, Cantu RC. Head and neck injuries in young athletes. Clin Sports Med 2000; 19:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/8\">",
"      Skellett S, Tibby SM, Durward A, Murdoch IA. Lesson of the week: Immobilisation of the cervical spine in children. BMJ 2002; 324:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/9\">",
"      Riggins RS, Kraus JF. The risk of neurologic damage with fractures of the vertebrae. J Trauma 1977; 17:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/10\">",
"      Podolsky S, Baraff LJ, Simon RR, et al. Efficacy of cervical spine immobilization methods. J Trauma 1983; 23:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/11\">",
"      Bonadio WA. Cervical spine trauma in children: Part I. General concepts, normal anatomy, radiographic evaluation. Am J Emerg Med 1993; 11:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/12\">",
"      Garfin SR, Shackford SR, Marshall LF, Drummond JC. Care of the multiply injured patient with cervical spine injury. Clin Orthop Relat Res 1989; :19.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Surgeons. Advanced Trauma Life Support Student Manual. Chicago 1997.",
"    </li>",
"    <li>",
"     www.forms.acsm.org/health+fitness/pdf/currentcomments/football052302.pdf (Accessed on February 15, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/15\">",
"      Treme G, Diduch DR, Hart J, et al. Cervical spine alignment in the youth football athlete: recommendations for emergency transportation. Am J Sports Med 2008; 36:1582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/16\">",
"      Swartz EE, Armstrong CW, Rankin JM, Rogers B. A 3-Dimensional Analysis of Face-Mask Removal Tools in Inducing Helmet Movement. J Athl Train 2002; 37:178.",
"     </a>",
"    </li>",
"    <li>",
"     Almquist JL, Schuler TC. Cervical spine injured athlete transfer protocol (videotape). Northern Virginia Spine Institute, Reston, VA, 1993.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/18\">",
"      Donaldson WF 3rd, Lauerman WC, Heil B, et al. Helmet and shoulder pad removal from a player with suspected cervical spine injury. A cadaveric model. Spine (Phila Pa 1976) 1998; 23:1729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/19\">",
"      Kumar SR, Weaver FA, Yellin AE. Cervical vascular injuries: carotid and jugular venous injuries. Surg Clin North Am 2001; 81:1331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/20\">",
"      Torg, JS, Booth, RE Jr, Albright, JP, et al. Symposium: athletic injuries to the cervical spine and brachial plexus. Contemp Orthop 1984; 9:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/21\">",
"      Anderson, C. Neck injuries, backboard, bench, or return to play? Phys Sportsmed 1993; 21:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15815/abstract/22\">",
"      Wiesenfarth J, Briner W Jr. Neck injuries: urgent decisions and actions. Phys Sportsmed 1996; 24:35.",
"     </a>",
"    </li>",
"    <li>",
"     Cantu RC. Criteria for return to competition after head or cervical spine injury. In: ACSM's Guidelines for the Team Physician, Cantu RC, Micheli LJ.  (Eds), Lea &amp; Febiger, Philadelphia 1991.",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6527 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-2522EA1FE6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15815=[""].join("\n");
var outline_f15_28_15815=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Equipment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SUSPICION AND RECOGNITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      STABILIZATION AND SAFETY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Immobilization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Helmet removal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      IMMEDIATE TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Airway and breathing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Circulation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Vascular injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      CERVICAL SPINE EVALUATION IN THE AMBULATORY ATHLETE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SECONDARY TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Methylprednisolone",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      RETURN TO PLAY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"EM/6527\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6527|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?8/62/9184\" title=\"algorithm 1\">",
"      Field management algorithm for C-spine injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6527|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/28/43470\" title=\"figure 1\">",
"      Jaw thrust",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6527|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?11/45/11999\" title=\"picture 1\">",
"      Spurling test",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"EM/6527|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/20/20811\" title=\"table 1\">",
"      Signs and symptoms of spinal cord injury",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/11/26810?source=related_link\">",
"      Acute traumatic spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/25/41368?source=related_link\">",
"      Approach to the young athlete with neck pain or injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/22/29030?source=related_link\">",
"      Basic airway management in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/43/7864?source=related_link\">",
"      Basic life support in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/48/29450?source=related_link\">",
"      Emergent endotracheal intubation in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/34/31274?source=related_link\">",
"      Evaluation and acute management of cervical spinal column injuries in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/7/32889?source=related_link\">",
"      Evaluation of cervical spine injuries in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/8/23689?source=related_link\">",
"      Overview of cervical spinal cord and cervical peripheral nerve injuries in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/49/11033?source=related_link\">",
"      Overview of musculoskeletal neck injuries in the young athlete",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/44/6854?source=related_link\">",
"      Pediatric cervical spine immobilization",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_28_15816="Behavioral strategies in the treatment of obesity";
var content_f15_28_15816=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Behavioral strategies in the treatment of obesity",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15816/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15816/contributors\">",
"     George A Bray, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15816/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15816/contributors\">",
"     F Xavier Pi-Sunyer, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15816/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15816/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/28/15816/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial management of overweight and obesity is lifestyle intervention, a combination of diet, exercise, and behavioral modification. This combination can produce weight losses of up to 10 percent. In addition, some patients eventually require the addition of pharmacologic therapy or bariatric surgery.",
"   </p>",
"   <p>",
"    The goal of behavioral therapy is to help patients make long-term changes in their eating behavior by modifying and monitoring their food intake, modifying their physical activity, and controlling cues and stimuli in the environment that trigger eating. The use of behavioral strategies to treat obesity is reviewed here. Other therapies for obesity, including drug therapy, specific diets, and specific exercise programs, are reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=see_link\">",
"     \"Overview of therapy for obesity in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=see_link\">",
"     \"Role of physical activity and exercise in obese adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=see_link\">",
"     \"Dietary therapy for obesity\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33866?source=see_link\">",
"     \"Drug therapy of obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     HISTORY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first report of a behavioral therapy for obesity was in 1967 [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/1\">",
"     1",
"    </a>",
"    ]. Since this initial report, the length and aggressiveness of treatment techniques have been extended and intensified. One report estimated that average weight loss in behavioral programs for overweight individuals had increased by approximately 75 percent between 1974 and 1994 [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Weight losses with the current programs can be up to 10 percent of initial body weight and are maximal within the first six months after the initiation of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Regrettably, as with other therapies for obesity, maintenance of these initial weight losses has been difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Duration of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;One of the major lessons of the past 30 years is that programs of greater length are more effective than those of shorter length. In the 1970s, behavioral weight loss programs typically lasted eight weeks with an average weight loss of 3.8 kg, but by the 1990s, as treatment duration lengthened, typical weight loss was 8.5 kg after 21 weeks of treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/2\">",
"     2",
"    </a>",
"    ]. Combining behavioral therapy with other methods can enhance the magnitude and duration of weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Assumptions and expectations",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two basic assumptions underlying behavioral therapy for overweight patients. The first is that obese individuals have learned maladaptive eating and exercise patterns that are contributing to weight gain",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    maintenance of their overweight state. The second is that these behaviors can be modified and that weight loss will result. With this theory, principles of learning from schools of classical and operant conditioning are applied in training new behaviors. Thus, behavioral treatment for the overweight patient seeks to alter the environment, to alter environmental reinforcement contingencies, and to shape eating behavior and physical activity.",
"   </p>",
"   <p>",
"    One of the key elements of human nature is perseverance. This concept applies to the search for new ways to lose weight that occurs on an almost annual basis. This cycle of failure and renewed effort has been labeled as a \"false hope syndrome\" [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/6\">",
"     6",
"    </a>",
"    ]. There are several reasons why self-change attempts fail:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Expectations often exceed what is feasible",
"     </li>",
"     <li>",
"      People often predict that they will change more quickly and more easily than is possible",
"     </li>",
"     <li>",
"      People overestimate their abilities in many domains and are unaware that they are inaccurate",
"     </li>",
"     <li>",
"      People often believe that making a change will improve their lives more than can reasonably be expected",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Dieters go through a number of explanations for their failure. The plateau that occurs with all weight loss efforts may be viewed by the dieter as the result of not trying hard enough. Some individuals blame the diet itself when it is unsuccessful. For the counselor, one option is to try another diet. However, cycling through the false hope syndrome often produces negative feelings and frustrations for the dieter. While some individuals are able to overcome these barriers and successfully lose weight, the failure rates remain high.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ELEMENTS OF BEHAVIORAL STRATEGIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The behavioral package that is currently used in most programs contains a number of components that are usually used together. These include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Self-monitoring (keeping food diaries and activity records)",
"     </li>",
"     <li>",
"      Control of the stimuli that activate eating",
"     </li>",
"     <li>",
"      Slowing down the eating process, goal setting",
"     </li>",
"     <li>",
"      Behavioral contracting and reinforcement",
"     </li>",
"     <li>",
"      Nutrition education and meal planning",
"     </li>",
"     <li>",
"      Modification of physical activity",
"     </li>",
"     <li>",
"      Social support",
"     </li>",
"     <li>",
"      Cognitive restructuring",
"     </li>",
"     <li>",
"      Problem-solving",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Lifestyle intervention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lifestyle intervention (combined diet, exercise, and behavioral treatment) is the most important strategy for weight management. One example of a successful lifestyle intervention program is the Diabetes Prevention Program (DPP) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/3\">",
"     3",
"    </a>",
"    ]. The two major goals of the DPP lifestyle intervention are a minimum of 7 percent weight loss and a minimum of 150 minutes of exercise per week (such as brisk walking). Some of the behavioral components listed above were used to help achieve these goals, including behavioral self-management training, individual case managers, group",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    individual sessions, individualized adherence strategies, and a network of training, feedback, and clinical support [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/7\">",
"     7",
"    </a>",
"    ]. Using this approach, the DPP reported that lifestyle intervention was more effective for preventing diabetes than a pharmacologic intervention (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/48/7944?source=see_link\">",
"     metformin",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=see_link\">",
"     \"Role of physical activity and exercise in obese adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=see_link\">",
"     \"Dietary therapy for obesity\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Frequent reinforcement of the lifestyle intervention is important for long-term success. In a trial of 376 obese patients receiving sibutramine who were randomly assigned to one of five different methods of delivering a lifestyle intervention program, those assigned to high-frequency in-person or telephone counseling lost a similar amount of weight at six months (8.9 and 7.7 percent of body weight, respectively) and significantly more than those assigned to the other groups (low-frequency in-person, high-frequency email, or no counseling, 5.2 to 5.9 percent of body weight) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Individual versus group therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Behavioral programs appear to be successful whether administered individually [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/3,9\">",
"     3,9",
"    </a>",
"    ] or in a group setting [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/10\">",
"     10",
"    </a>",
"    ]. While some patients might prefer individual therapy, the group setting may be more cost-effective, as a single therapist can handle up to 15 or more participants.",
"   </p>",
"   <p>",
"    A resource that patients may find useful for learning individual behavioral strategies is the LEARN Program for Weight Management 2000 [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Self-monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;Self-monitoring, often involving the use of food diaries and activity records, is one of the key elements in a successful behavioral weight loss program. The participants are instructed in how to record everything they eat and the calories in the food, as well as the situation in which they are eating. It is predictive of success during a weight loss program and is used daily during the first four to six months and then continued as needed. The National Weight Control registry reports that self-monitoring is one of the techniques most frequently used among patients who lose weight and maintain the weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The importance of self-monitoring was illustrated in a placebo-controlled trial of sibutramine therapy in a group of patients receiving both sibutramine and lifestyle modification. Those who recorded their food intake more frequently lost more than twice as much weight as those who did not (18.1 versus 7.7 kg, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Stimulus control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stimulus control is considered a key element in a behavioral program [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/13\">",
"     13",
"    </a>",
"    ]. It focuses on gaining control over the environmental factors that activate eating and eliminating or modifying the environmental factors that facilitate over-eating. Since food is a key issue in weight gain, participants are taught to buy more fresh fruits and vegetables, to prepare easy-to-eat lower calorie foods, and to place them prominently in the refrigerator or on the counter.",
"   </p>",
"   <p>",
"    The proximity of food and the shape and size of serving containers may influence how much is eaten [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/14\">",
"     14",
"    </a>",
"    ]. Stimulus control also includes making the act of eating a focus of its own. Thus, turning off the television set and putting down reading materials may allow the individual to concentrate on eating.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Slowing down the rate of eating",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since eating is central to ingesting food, slowing down the process may give \"physiological\" signals for fullness time to come into play. Two ways to slow down eating include concentrating on the tastes of the food and savoring what is being eaten. Other techniques might involve leaving the table briefly during a meal and drinking water between bites.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Setting realistic goals",
"    </span>",
"    &nbsp;&mdash;&nbsp;Changes in eating behavior require time and commitment and it is important for the patient and therapist to set realistic weight loss goals, such as 0.5 to 1",
"    <span class=\"nowrap\">",
"     kg/week",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/15\">",
"     15",
"    </a>",
"    ]. To achieve this goal, participants are encouraged to reduce energy intake by 1000",
"    <span class=\"nowrap\">",
"     kcal/day,",
"    </span>",
"    which can be done with diet instruction, provision of food or the use of portion-controlled foods. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=see_link&amp;anchor=H2#H2\">",
"     \"Dietary therapy for obesity\", section on 'Goals of weight loss'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Behavioral contracting and reinforcement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Reinforcing successful outcomes is important, and providing small tokens for success may be beneficial. For example, patients can earn credit for gasoline or merchandise (not food) for successful completion of various activities in a behavior program.",
"   </p>",
"   <p>",
"    Financial incentives can also serve to enhance weight loss. As an example, in a 16-week randomized trial comparing two incentive-based approaches (lottery and deposit contract interventions) with a control group (monthly weigh-ins) in 57 healthy, obese (BMI 30 to 40",
"    <span class=\"nowrap\">",
"     kg/m2),",
"    </span>",
"    predominantly male (94.7 percent) subjects, mean weight loss was significantly greater in the lottery (5.95 kg) and deposit contract (6.36 kg) groups compared with controls (1.77 kg) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/16\">",
"     16",
"    </a>",
"    ]. The weight loss goal of 7.27 kg (16 lbs) was met by 52.6, 47.4, and 10.5 percent of subjects in each group. Although weight gain occurred over the ensuing three months, the financial incentive groups weighed significantly less than at baseline, but control subjects did not.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Nutritional education and meal planning",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nutrition education and meal planning are also important behavior strategies. Providing a defined meal structure results in greater weight loss than in the absence of such a structure [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/2,12\">",
"     2,12",
"    </a>",
"    ]. Use of portion-controlled plates [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/17\">",
"     17",
"    </a>",
"    ] or diets is one of the strategies for providing this structured environment for eating.",
"   </p>",
"   <p>",
"    Dietary counseling appears to facilitate weight loss, particularly during the first year of weight loss programs [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Increasing physical activity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increasing physical activity is another part of a successful behavioral program. In addition to self-monitoring, increasing physical activity was a key element in success for members of the National Weight Control Registry [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/12\">",
"     12",
"    </a>",
"    ]. In this group of more than 4000 individuals who had lost at least 13.6 kg (30 lbs) and kept it off for at least one year, increasing physical activity was an important element in success. These individuals had lost an average of 33 kg and maintained it for an average of 5.7 years. Women in the Registry reported expending 2545",
"    <span class=\"nowrap\">",
"     kcal/week",
"    </span>",
"    in exercise and men, 3293",
"    <span class=\"nowrap\">",
"     kcal/week",
"    </span>",
"    in exercise. This would be equivalent to about one hour per day of moderate-intensity activity, such as brisk walking [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/12\">",
"     12",
"    </a>",
"    ]. The importance of exercise in obesity is reviewed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=see_link\">",
"     \"Role of physical activity and exercise in obese adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Social support",
"    </span>",
"    &nbsp;&mdash;&nbsp;Enhancing social support may also be a means for improving long-term weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/19\">",
"     19",
"    </a>",
"    ]. Inclusion of family members or spouses is one of the best ways to accomplish this. There are both short-term and long-term benefits to programs that include strong family support. In a meta-analysis of four 12-month behavioral programs that included family members, mean weight loss in the family-based intervention was approximately 3 kg more than in the control behavioral programs [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Social support can also work to the advantage of the family member not participating in the trial. In the Look AHEAD trial, which is a randomized trial of intensive lifestyle modification in patients with type 2 diabetes, the spouses of those in the intervention group lost 2.2 to 4.4 kg, whereas spouses of those in the control group gained up to 3.3 kg in body weight [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/20\">",
"     20",
"    </a>",
"    ]. The Look AHEAD trial is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43577?source=see_link&amp;anchor=H9#H9\">",
"     \"Initial management of blood glucose in type 2 diabetes mellitus\", section on 'Intensive lifestyle modification'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although unproven, a number of behavioral tools may help with weight loss:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cognitive restructuring &mdash; adopting positive rather than negative self-talk (for example, if one eats a piece of cake, choosing to exercise rather than blaming oneself)",
"     </li>",
"     <li>",
"      Problem-solving &mdash; developing strategies to manage food intake in difficult situations such as restaurants and parties",
"     </li>",
"     <li>",
"      Assertiveness training &mdash; learning to say \"no\"",
"     </li>",
"     <li>",
"      Stress reduction &mdash; identifying and reducing stressors that are triggers for eating",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Behavioral-based treatment programs improve weight loss results, at least in the short term [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/10,18,21\">",
"     10,18,21",
"    </a>",
"    ]. As an example, in a systematic review of 38 trials assessing behaviorally-based interventions compared with usual care, most trials showed a statistically significant effect on weight loss with the intervention at 12 to 18 months [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/21\">",
"     21",
"    </a>",
"    ]. The interventions included regular patient education sessions (eg, healthy diet choices, physical activity, weight loss goals, barriers to weight loss), regular weight checks, and peer support. The intervention groups lost 1.5 to 5 kg, whereas controls lost little or no weight. Subjects participating in behavioral interventions that included more sessions (12 to 26) lost more weight (4 to 7 versus 1.5 to 4 kg) than those participating in fewer than 12 sessions.",
"   </p>",
"   <p>",
"    In subsequent trials lasting 24 months, behavioral interventions produced modest weight loss compared with usual care (mean difference in weight 0.5 to 1 kg) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. In one trial, the benefit of the behavioral intervention was significant at 6 and 12 months but was not sustained at 24 months (mean difference in weight 1.7, 1.6, and 0.6 kg, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/23\">",
"     23",
"    </a>",
"    ]. These data suggest that behavioral interventions alone do not produce long-term benefit, particularly when participation in the intervention wanes over time.",
"   </p>",
"   <p>",
"    Behavioral interventions in conjunction with drug (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/32/5638?source=see_link\">",
"     orlistat",
"    </a>",
"    ) or dietary (meal replacements) therapy are more effective than routine care, as illustrated by the results of a randomized trial examining three different lifestyle interventions (usual care [quarterly primary care visits with five to seven minutes spent reviewing weight loss plans], brief counseling [usual care plus 10 to 15 minutes each month with a lifestyle coach], and enhanced counseling [brief counseling plus meal replacements, orlistat, or sibutramine]) in 390 obese adults [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/24\">",
"     24",
"    </a>",
"    ]. After two years, mean weight loss was 1.7, 2.9, and 4.6 kg, respectively. Initial weight decreased at least 5 percent in 21.5, 26, and 34.9 percent, respectively. These outcomes were significantly better in the enhanced lifestyle counseling group compared with usual care, but there were no significant differences among the other groups.",
"   </p>",
"   <p>",
"    There are few data on long-term health outcomes (mortality, cardiovascular disease). However, interventions that are successful in reducing weight also reduce diabetes risk, particularly in patients with impaired glucose tolerance or impaired fasting glucose at baseline [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/21\">",
"     21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=see_link&amp;anchor=H12#H12\">",
"     \"Prediction and prevention of type 2 diabetes mellitus\", section on 'Weight loss/lifestyle intervention'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Self-help or commercial weight loss programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each year, many overweight and obese patients enroll in self-help or commercial weight loss programs in spite of suboptimal efficacy data. These programs incorporate varying degrees of behavioral modification strategies. A systematic review of the major available programs in the United States reported the following [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/25\">",
"     25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The two largest self-help programs were Take Off Pounds Sensibly (TOPS) and Overeaters Anonymous, both not-for-profit groups. There is little evidence to suggest that these programs are effective, but the costs and risks appear to be minimal. Some patients find the emotional support offered in these programs to be helpful.",
"     </li>",
"     <li>",
"      The three largest commercial programs were Weight Watchers, Jenny Craig, and LA Weight Loss. At the time of the systematic review, only one of these, Weight Watchers, had funded clinical trials to determine efficacy. In a two-year, multicenter trial of 423 subjects randomly assigned to attendance at weekly meetings versus a \"self-help\" control group (two 20-minute sessions with a nutritionist and provision of printed materials), those in the Weight Watchers group lost 5.3 percent of their initial weight after one year, and maintained a loss of 3.2 percent after two years (compared with 1.5 and 0 percent, respectively, in the control group) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/26\">",
"       26",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a subsequent trial comparing Jenny Craig with usual care (consultation with a dietician at baseline and six months and provision of printed material) in 442 overweight or obese women (mean BMI 34",
"    <span class=\"nowrap\">",
"     kg/m2),",
"    </span>",
"    subjects who participated in the Jenny Craig program lost significantly more weight after two years (6.8 to 7.9 percent of their initial weight, compared with 2.1 percent in the control group) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/27\">",
"     27",
"    </a>",
"    ]. In both groups, weight loss occurred during the first 12 months, followed by a slight weight gain between 12 and 24 months. Attenuation of weight loss between 12 and 24 months was higher in the Jenny Craig group (27 percent versus 17 percent), suggesting greater difficulty with maintenance of weight loss (see",
"    <a class=\"local\" href=\"#H20\">",
"     'Maintenance of weight loss'",
"    </a>",
"    below). In addition, Jenny Craig participants were provided with free prepared meals and, therefore, the attrition rate was low. Whether the average obese patient who is paying for this plan will achieve similar results is unknown.",
"   </p>",
"   <p>",
"    A trial from the UK compared six weight loss programs (three commercial programs and three provided by the National Health Service) with a minimal intervention comparator group that was provided with vouchers to a fitness center [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/28\">",
"     28",
"    </a>",
"    ]. After 12 weeks, mean weight loss ranged from 4.4 to 1.4 kg. Participants in the commercial weight loss programs (Weight Watchers and Rosemary Conley) had significantly greater weight loss than the control group. After one year, only the Weight Watchers group had significantly greater weight loss than the comparator group (mean difference -2.38 kg, 95% CI -3.98 to -0.78). Weight Watchers had the highest proportion of persons attending 50 percent or more sessions, reinforcing attendance as an important determinant of success.",
"   </p>",
"   <p>",
"    Thus, commercial weight loss programs can be expensive, sometimes employ very low calorie diets, and only occasionally have been evaluated in controlled clinical trials [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/25-29\">",
"     25-29",
"    </a>",
"    ]. A principal determinant of weight loss appears to be the degree of adherence to the program. Thus patient preference is an important consideration when recommending any weight loss programs. Since the commercial programs do not carry any higher risk than other dietary programs, the patient and health care provider can select among programs, with the recommendation that programs with clinically demonstrated efficacy would be the first choice.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Internet-based programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Internet-based weight loss programs are widely available, including some self-help and commercial weight loss programs that traditionally used only group meetings [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/30-38\">",
"     30-38",
"    </a>",
"    ]. Efficacy data for internet programs are mixed. In a systematic review of 18 weight loss trials, approximately 50 percent of the trials reported significantly greater weight loss among participants randomly assigned to the internet intervention than to control conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/39\">",
"     39",
"    </a>",
"    ]. Several trials suggest that programs that include a behavior modification component are more effective than those that do not:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one randomized trial of 124 overweight subjects, weight loss was greater after 12 months in those who used a structured, behavioral weight loss website when compared with a self-help commercial website (7.8 kg versus 3.4 kg, respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another trial reported that the addition of behavioral counseling (e-counseling) to a basic internet weight loss program resulted in greater weight loss at 12 months (4.4 kg versus 2 kg in subjects using the basic internet program only) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, internet weight loss programs that incorporate behavior modification may be more effective than internet programs that do not.",
"   </p>",
"   <p>",
"    Behavioral programs delivered remotely may be equally as effective as in-person programs. As an example, in a randomized trial of a face-to-face or a remote behavioral intervention compared with control (no intervention) in 415 obese patients, mean change in weight from baseline was similar at 24 months in the groups receiving the behavioral intervention (-5.1 and -4.6 kg, respectively, compared with -0.8 kg in the control group) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/41\">",
"     41",
"    </a>",
"    ]. The remote intervention used telephone, a study-specific Web site, and email to provide patients with behavioral support. Participation in the face-to-face behavioral intervention declined during the course of the study. The median number of group sessions attended was 6.5 in the first six months and one in the next 18 months. The median number of individual sessions attended also decreased (four in the first six months and one in the last 18 months). In the remote group, the median number of completed phone calls was 14 of 15 recommended in the first six months and 16 of 18 recommended for the remainder of the trial. These data suggest that remote behavioral interventions present fewer barriers to adherence than in-person interventions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Maintenance of weight loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although many individuals have success losing weight with diet",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    behavioral therapy, most patients subsequently regain the lost weight. Behavioral interventions may be helpful for maintaining weight loss [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/36,39,42-44\">",
"     36,39,42-44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was illustrated in a trial of 314 patients who had lost a mean of 19 kg in the previous two years who were then randomly assigned to one of three groups: a group that received quarterly newsletters (control), a group that received internet-based behavioral intervention, and a group that received the behavioral intervention face-to-face [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/42\">",
"     42",
"    </a>",
"    ]. The content of the intervention, emphasizing self-weighing and self-regulation, was the same for the two experimental groups.",
"   </p>",
"   <p>",
"    At 18 months of follow-up, patients in the face-to-face group gained less weight (2.5 kg) compared with the internet and control groups (4.7 and 4.9 kg, respectively). However, the proportion of participants who regained 2.3 kg or more was similar in the face-to-face and internet groups (45.7 and 54.8 percent, respectively), but higher in the control group (72.4 percent). Thus, intervention that emphasizes self-weighing and self-regulation may be helpful for maintenance of weight loss, particularly if delivered face-to-face.",
"   </p>",
"   <p>",
"    Similar results were seen in a second trial in which patients randomized to monthly personal contact for 30 months after an initial weight loss. They regained less weight over the next 18 months than patients randomized to an interactive technology-based intervention or self-directed control, but by the end of 30 months this difference was gone [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, a third, randomized trial of 254 subjects reported that maintenance of weight loss was as good with internet-based support as with in-person support [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/36\">",
"     36",
"    </a>",
"    ]. In this study, attendance at treatment meetings and chat room sessions, as well as frequency of self-monitoring, were related to successful maintenance.",
"   </p>",
"   <p>",
"    In summary, use of behavioral strategies may be helpful for maintenance of weight loss. Data are conflicting on whether face-to-face interventions are more effective than internet-based interventions. Some patients may prefer internet programs for convenience and possibly lower cost.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Children and adolescents",
"    </span>",
"    &nbsp;&mdash;&nbsp;Behavioral therapies also appear to be helpful in children and adolescents. Important components for success include parental involvement [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/45\">",
"     45",
"    </a>",
"    ] and motivating children to reduce inactivity (mainly by decreasing television time) (",
"    <a class=\"graphic graphic_figure graphicRef78166 \" href=\"UTD.htm?3/14/3311\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The internet has been utilized for weight loss and weight maintenance in adolescents and children with variable results [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15816/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. Pediatric obesity is reviewed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=see_link\">",
"     \"Definition; epidemiology; and etiology of obesity in children and adolescents\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18378?source=see_link\">",
"     \"Management of childhood obesity in the primary care setting\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal management of overweight and obesity starts with a combination of diet, exercise, and behavioral modification. In addition, some patients eventually need the options of adding pharmacologic therapy or bariatric surgery.",
"   </p>",
"   <p>",
"    Behavioral treatment of obesity has become a standard part of most treatment programs in the last 35 years. The goal of this approach is to help patients make long-term changes in their eating behavior by modifying and monitoring their food intake, increasing their physical activity, and controlling cues and stimuli in the environment that trigger eating. Physical activity and self-monitoring are particularly important components for success.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For overweight and obese patients who are attempting to lose weight, we suggest weight loss programs that include behavior modification strategies (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      For overweight and obese patients who have lost weight, we suggest that behavior modification strategies be continued to minimize subsequent weight gain (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The choice of an internet-based or an in-person behavioral weight loss program depends upon patient preference. Some may prefer the convenience and possible lower cost of internet programs, while others may prefer the support provided by individual or group sessions.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/1\">",
"      Stuart, RB. Behavioral control of overeating. Behav Res Ther 1967; 5:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/2\">",
"      Jeffery RW, Drewnowski A, Epstein LH, et al. Long-term maintenance of weight loss: current status. Health Psychol 2000; 19:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/3\">",
"      Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/4\">",
"      Perri MG, Nezu AM, McKelvey WF, et al. Relapse prevention training and problem-solving therapy in the long-term management of obesity. J Consult Clin Psychol 2001; 69:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/5\">",
"      Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005; 353:2111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/6\">",
"      Polivy J, Herman CP. If at first you don't succeed. False hopes of self-change. Am Psychol 2002; 57:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/7\">",
"      Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002; 25:2165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/8\">",
"      Digenio AG, Mancuso JP, Gerber RA, Dvorak RV. Comparison of methods for delivering a lifestyle modification program for obese patients: a randomized trial. Ann Intern Med 2009; 150:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/9\">",
"      Wing RR, Hamman RF, Bray GA, et al. Achieving weight and activity goals among diabetes prevention program lifestyle participants. Obes Res 2004; 12:1426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/10\">",
"      Avenell A, Broom J, Brown TJ, et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8:iii.",
"     </a>",
"    </li>",
"    <li>",
"     Brownell KD. The LEARN Program for Weight Management 2000, American Health Publishing, Dallas, TX 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/12\">",
"      Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 2005; 82:222S.",
"     </a>",
"    </li>",
"    <li>",
"     Wing RR. Behavioral approaches to the treatment of obesity. In: Handbook of Obesity: Clinical Applications, 2nd Ed, Bray GA, Bouchard C (Eds), Marcel Dekker, New York 2004.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/14\">",
"      Wansink B, Cheney MM. Super Bowls: serving bowl size and food consumption. JAMA 2005; 293:1727.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/15\">",
"      Bandura, A, Simon, KM. The role of proximal intentions in self-regulation of refractory behavior. Cognit Ther Res 1977; 1:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/16\">",
"      Volpp KG, John LK, Troxel AB, et al. Financial incentive-based approaches for weight loss: a randomized trial. JAMA 2008; 300:2631.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/17\">",
"      Pedersen SD, Kang J, Kline GA. Portion control plate for weight loss in obese patients with type 2 diabetes mellitus: a controlled clinical trial. Arch Intern Med 2007; 167:1277.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/18\">",
"      Dansinger ML, Tatsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med 2007; 147:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/19\">",
"      McLean N, Griffin S, Toney K, Hardeman W. Family involvement in weight control, weight maintenance and weight-loss interventions: a systematic review of randomised trials. Int J Obes Relat Metab Disord 2003; 27:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/20\">",
"      Gorin AA, Wing RR, Fava JL, et al. Weight loss treatment influences untreated spouses and the home environment: evidence of a ripple effect. Int J Obes (Lond) 2008; 32:1678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/21\">",
"      Leblanc ES, O'Connor E, Whitlock EP, et al. Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2011; 155:434.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/22\">",
"      Bennett GG, Warner ET, Glasgow RE, et al. Obesity treatment for socioeconomically disadvantaged patients in primary care practice. Arch Intern Med 2012; 172:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/23\">",
"      Ross R, Lam M, Blair SN, et al. Trial of prevention and reduction of obesity through active living in clinical settings: a randomized controlled trial. Arch Intern Med 2012; 172:414.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/24\">",
"      Wadden TA, Volger S, Sarwer DB, et al. A two-year randomized trial of obesity treatment in primary care practice. N Engl J Med 2011; 365:1969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/25\">",
"      Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med 2005; 142:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/26\">",
"      Heshka S, Anderson JW, Atkinson RL, et al. Weight loss with self-help compared with a structured commercial program: a randomized trial. JAMA 2003; 289:1792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/27\">",
"      Rock CL, Flatt SW, Sherwood NE, et al. Effect of a free prepared meal and incentivized weight loss program on weight loss and weight loss maintenance in obese and overweight women: a randomized controlled trial. JAMA 2010; 304:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/28\">",
"      Jolly K, Lewis A, Beach J, et al. Comparison of range of commercial or primary care led weight reduction programmes with minimal intervention control for weight loss in obesity: lighten Up randomised controlled trial. BMJ 2011; 343:d6500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/29\">",
"      Jebb SA, Ahern AL, Olson AD, et al. Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial. Lancet 2011; 378:1485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/30\">",
"      Burnett KF, Taylor CB, Agras WS. Ambulatory computer-assisted therapy for obesity: a new frontier for behavior therapy. J Consult Clin Psychol 1985; 53:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/31\">",
"      Tate DF, Wing RR, Winett RA. Using Internet technology to deliver a behavioral weight loss program. JAMA 2001; 285:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/32\">",
"      Harvey-Berino J, Pintauro SJ, Gold EC. The feasibility of using Internet support for the maintenance of weight loss. Behav Modif 2002; 26:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/33\">",
"      Tate DF, Jackvony EH, Wing RR. Effects of Internet behavioral counseling on weight loss in adults at risk for type 2 diabetes: a randomized trial. JAMA 2003; 289:1833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/34\">",
"      Harvey-Berino J, Pintauro S, Buzzell P, et al. Does using the Internet facilitate the maintenance of weight loss? Int J Obes Relat Metab Disord 2002; 26:1254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/35\">",
"      Womble LG, Wadden TA, McGuckin BG, et al. A randomized controlled trial of a commercial internet weight loss program. Obes Res 2004; 12:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/36\">",
"      Harvey-Berino J, Pintauro S, Buzzell P, Gold EC. Effect of internet support on the long-term maintenance of weight loss. Obes Res 2004; 12:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/37\">",
"      Winett RA, Tate DF, Anderson ES, et al. Long-term weight gain prevention: a theoretically based Internet approach. Prev Med 2005; 41:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/38\">",
"      Napolitano MA, Fotheringham M, Tate D, et al. Evaluation of an internet-based physical activity intervention: a preliminary investigation. Ann Behav Med 2003; 25:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/39\">",
"      Rao G, Burke LE, Spring BJ, et al. New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation 2011; 124:1182.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/40\">",
"      Gold BC, Burke S, Pintauro S, et al. Weight loss on the web: A pilot study comparing a structured behavioral intervention to a commercial program. Obesity (Silver Spring) 2007; 15:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/41\">",
"      Appel LJ, Clark JM, Yeh HC, et al. Comparative effectiveness of weight-loss interventions in clinical practice. N Engl J Med 2011; 365:1959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/42\">",
"      Wing RR, Tate DF, Gorin AA, et al. A self-regulation program for maintenance of weight loss. N Engl J Med 2006; 355:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/43\">",
"      Svetkey LP, Stevens VJ, Brantley PJ, et al. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008; 299:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/44\">",
"      Dale KS, McAuley KA, Taylor RW, et al. Determining optimal approaches for weight maintenance: a randomized controlled trial. CMAJ 2009; 180:E39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/45\">",
"      Epstein LH, Valoski A, Wing RR, McCurley J. Ten-year follow-up of behavioral, family-based treatment for obese children. JAMA 1990; 264:2519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/46\">",
"      Epstein LH, Valoski AM, Vara LS, et al. Effects of decreasing sedentary behavior and increasing activity on weight change in obese children. Health Psychol 1995; 14:109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/47\">",
"      Baranowski T, Baranowski JC, Cullen KW, et al. The Fun, Food, and Fitness Project (FFFP): the Baylor GEMS pilot study. Ethn Dis 2003; 13:S30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15816/abstract/48\">",
"      Williamson DA, Martin PD, White MA, et al. Efficacy of an internet-based behavioral weight loss program for overweight adolescent African-American girls. Eat Weight Disord 2005; 10:193.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5382 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-213.131.41.98-90976AC03E-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15816=[""].join("\n");
var outline_f15_28_15816=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      HISTORY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Duration of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Assumptions and expectations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ELEMENTS OF BEHAVIORAL STRATEGIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Lifestyle intervention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Individual versus group therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Self-monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Stimulus control",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Slowing down the rate of eating",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Setting realistic goals",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Behavioral contracting and reinforcement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Nutritional education and meal planning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Increasing physical activity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Social support",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Self-help or commercial weight loss programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Internet-based programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Maintenance of weight loss",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/5382\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/5382|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/14/3311\" title=\"figure 1\">",
"      Physical activity and weight loss in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/5/32858?source=related_link\">",
"      Definition; epidemiology; and etiology of obesity in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/9/8345?source=related_link\">",
"      Dietary therapy for obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/4/33866?source=related_link\">",
"      Drug therapy of obesity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/35/43577?source=related_link\">",
"      Initial management of blood glucose in type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/60/18378?source=related_link\">",
"      Management of childhood obesity in the primary care setting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/45/13016?source=related_link\">",
"      Overview of therapy for obesity in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/30/29162?source=related_link\">",
"      Prediction and prevention of type 2 diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/41/21144?source=related_link\">",
"      Role of physical activity and exercise in obese adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_28_15817="Pollen-food cross reactivity PI";
var content_f15_28_15817=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F58854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F58854&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 628px\">",
"   <div class=\"ttl\">",
"    Cross-reactivity patterns in pollen-food allergy syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 608px; height: 786px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical patterns of cross-reactivity between pollens and fruits and vegetables. Individual foods are grouped by their taxonomical families.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted and extended from: Sicherer SH. Clinical implications of cross-reactive food allergens. J Allergy Clin Immunol 2001; 108:881.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15817=[""].join("\n");
var outline_f15_28_15817=null;
var title_f15_28_15818="Pathophysiology of diastolic heart failure";
var content_f15_28_15818=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathophysiology of diastolic heart failure",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Michael R Zile, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Laura Wexler, MD, FACC, FAHA",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15818/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Wilson S Colucci, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?15/28/15818/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?15/28/15818/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 6, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Heart failure (HF) can be defined as the inability of the heart to provide sufficient forward output to meet the perfusion and oxygenation requirements of the tissues while maintaining normal filling pressures. There are two major mechanisms by which this can occur:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systolic dysfunction, in which there is impaired cardiac contractile function.",
"     </li>",
"     <li>",
"      Diastolic dysfunction, in which there is abnormal cardiac relaxation, stiffness or filling.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The pathophysiology of diastolic HF will be reviewed here. The clinical manifestations, diagnosis, treatment and prognosis of diastolic HF, and the management of systolic HF are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=see_link\">",
"     \"Clinical manifestations and diagnosis of diastolic heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7018?source=see_link\">",
"     \"Treatment and prognosis of diastolic heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=see_link\">",
"     \"Overview of the therapy of heart failure due to systolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TERMINOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is important to define and distinguish several terms when classifying patients with HF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Systolic versus diastolic HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with chronic HF can be divided into two categories on the basis of characteristic changes in cardiovascular structure and function (",
"    <a class=\"graphic graphic_figure graphicRef87847 \" href=\"UTD.htm?17/60/18371\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Systolic HF (SHF) is characterized by abnormalities in systolic function (ie, reduced left ventricular ejection fraction [LVEF]) usually with progressive chamber dilation and eccentric remodeling. Because the dominant abnormality is in systolic function, this syndrome is called SHF. This syndrome is also called HF with a reduced LVEF (HFrEF). SHF has been defined by a variety of LVEF partition values ranging from less than 35 to 50 percent. Our preference is to define SHF by an LVEF &lt;50 percent.",
"     </li>",
"     <li>",
"      Diastolic HF (DHF) is characterized by a normal LVEF, normal LV end-diastolic volume, and abnormal diastolic function, usually with concentric remodeling or hypertrophy [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/2,4-8\">",
"       2,4-8",
"      </a>",
"      ]. The dominant abnormality resides in diastole. However, in clinical practice, the diagnosis of DHF is often one of exclusion based on the finding of a normal or near normal (or &ldquo;preserved&rdquo;) LVEF. As a result, this syndrome is also called &ldquo;HF with preserved EF&rdquo; (HFpEF). As discussed below, DHF may be best defined as HF with LVEF &gt;50 percent and evidence of diastolic dysfunction.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    SHF and DHF are distinct syndromes, not a continuous spectrum of disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/9\">",
"     9",
"    </a>",
"    ]. Distinctions between DHF and SHF include epidemiologic differences, LV morphologic differences, as well as differences in the cardiomyocytes and extracellular matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/10-12\">",
"     10-12",
"    </a>",
"    ]. In addition, two sets of data (Dallas Heart Study and the Cardiovascular Heart Study) have shown that conversion from DHF to SHF is uncommon and generally associated with an incident injury (such as myocardial infarction) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Patients with SHF may have evidence of diastolic dysfunction, particularly during periods of symptomatic decompensation [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/15-18\">",
"     15-18",
"    </a>",
"    ]. Likewise, patients with DHF may have subtle abnormalities in regional systolic function [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/2,8\">",
"     2,8",
"    </a>",
"    ]. Epidemiologic studies, pathophysiologic studies, and randomized clinical studies have found differences in clinical characteristics, in structure at both macroscopic and microscopic levels, in function, and in outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/12,13,19,20\">",
"     12,13,19,20",
"    </a>",
"    ]. These differences indicate that SHF and DHF are distinct phenotypes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8876701\">",
"    <span class=\"h2\">",
"     HFpEF versus diastolic HF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately half of all patients with chronic HF have a normal or near normal (ie, &ldquo;preserved&rdquo;) left ventricular ejection fraction (LVEF) known as HFpEF. HFpEF is a clinical syndrome characterized by symptoms and signs of HF, a preserved LVEF, and abnormal diastolic function. The term &ldquo;preserved&rdquo; LVEF refers to LVEFs that are normal or very near normal.",
"   </p>",
"   <p>",
"    The average LVEF for a healthy adult population is approximately 60 to 70 percent with a lower boundary (two standard deviations below the mean) that approaches 50 to 55 percent. An LVEF between 35 and 50 percent is clearly abnormal but LVEFs &ge;35 percent are often referred to as &ldquo;preserved.&rdquo; Most authors reserve the term diastolic HF for patients with symptoms and signs of HF, an LVEF &gt;50 percent and evidence of diastolic dysfunction. Diagnosis of diastolic HF requires the presence of diastolic dysfunction since there are causes of HF other than diastolic dysfunction in patients with preserved LVEF (eg, valve disease) (",
"    <a class=\"graphic graphic_table graphicRef54975 \" href=\"UTD.htm?19/7/19580\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The use of the term HFpEF became necessary to describe HF populations studied in recent randomized clinical trials in which various lower limit boundaries for the LVEF were allowed (between 35 and 50 percent) (",
"    <a class=\"graphic graphic_figure graphicRef69901 \" href=\"UTD.htm?40/15/41213\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. The focus of these studies was on HF patients for whom there are no evidence-based treatment strategies to reduce morbidity and mortality. These studies therefore focused on patients with HF and an LVEF &gt;35 percent or &gt;40 percent or &gt;45 percent, all of which have now been grouped as &ldquo;HFpEF.&rdquo; These populations should be thought of as different from those with HF and an LVEF &gt;50 percent (ie, patients with true DHF). Data from recent studies suggest that the epidemiology, natural history, and response to treatment in patients with HF and an LVEF between 35 and 50 percent are different from patients with HF and an LVEF &gt;50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/21-25\">",
"     21-25",
"    </a>",
"    ]. In fact, it is becoming evident that patients with HF and an LVEF between 35 and 50 percent share many or most characteristics with patients with HF and an LVEF &lt;35 percent. Therefore, it may be more appropriate to group patients with LVEFs 35 to 50 percent with the HFrEF group so that patients with HF are categorized into two groups: SHF defined as HF with LVEF&lt;50 percent and DHF defined as HF with LVEF &gt;50 percent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Diastolic dysfunction versus DHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diastolic dysfunction and diastolic HF are not synonymous terms [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/26\">",
"     26",
"    </a>",
"    ]. Diastolic dysfunction indicates a functional abnormality of diastolic relaxation, filling, or distensibility of the left ventricle (LV), regardless of whether the LVEF is normal or abnormal and whether the patient is symptomatic or not. Thus, diastolic dysfunction refers to abnormal mechanical properties of the ventricle. DHF denotes the signs and symptoms of clinical HF in a patient with a normal LVEF and LV diastolic dysfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is ongoing discussion about the most appropriate nomenclature and precise diagnostic criteria to apply to HF patients. The approach to the diagnosis of DHF is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=see_link\">",
"     \"Clinical manifestations and diagnosis of diastolic heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY OF LEFT VENTRICULAR DIASTOLE",
"    </span>",
"    &nbsp;&mdash;&nbsp;An appreciation of normal diastolic function permits a better understanding of the clinical features of DHF. Cardiac function is critically dependent upon diastolic physiologic mechanisms to provide adequate LV filling (cardiac input) in parallel with LV ejection (cardiac output). These processes must function under a variety of physiologic conditions, both at rest and during exercise.",
"   </p>",
"   <p>",
"    LV diastolic pressure is determined by the volume of blood in the ventricle and the distensibility or compliance of the ventricle. During diastole the LV, LA, and pulmonary veins form a \"common chamber,\" which is continuous with the pulmonary capillary bed (",
"    <a class=\"graphic graphic_figure graphicRef74512 \" href=\"UTD.htm?20/25/20880\">",
"     figure 3",
"    </a>",
"    ). Thus, an increase in LV diastolic pressure will increase pulmonary venous pressure, which can cause dyspnea, exercise limitation, and pulmonary congestion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Events during diastole",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diastole begins with the relaxation of the contracted myocardium. This is a dynamic, energy-dependent, process that includes two phases (",
"    <a class=\"graphic graphic_figure graphicRef61186 \" href=\"UTD.htm?0/59/948\">",
"     figure 4",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Isovolumic relaxation &mdash; Isovolumic relaxation is the period between aortic valve closure and mitral valve opening during which LV pressure declines with no change in volume.",
"     </li>",
"     <li>",
"      Auxotonic relaxation &mdash; During the period of auxotonic relaxation the LV fills at variable pressure beginning with mitral valve opening and ending by mid diastole in normal individuals and most patients.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During diastole, the rapid pressure decay associated with the \"untwisting\" and elastic recoil of the LV produce a suction effect that promotes ventricular filling by increasing the LA-LV pressure gradient and pulling blood into the ventricle. This process is augmented during exercise to compensate for the reduced diastolic filling period induced by the associated increase in heart rate. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Normal response to exercise'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    During the later phases of diastole, cardiomyocytes are relaxed and the normal LV is compliant and readily distensible, with minimal resistance to additional LV filling over a normal volume range. Atrial contraction contributes 20 to 30 percent to total LV filling volume, but usually increases diastolic pressures by less than 5 mmHg.",
"   </p>",
"   <p>",
"    Normal diastolic properties allow LV filling to be accomplished by very low filling pressures in the LA and pulmonary veins, thereby preserving a low pulmonary capillary pressure (&lt;12 mmHg) and a high degree of lung distensibility. Loss of normal LV diastolic relaxation and distensibility impairs LV filling, resulting in increases in LV, LA, and pulmonary venous pressures during diastole, which directly increase the pulmonary capillary pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Normal response to exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cardiac output can increase several-fold during exercise, an appropriate response to the enhanced needs of exercising muscle. Multiple factors contribute to this response including an increase in heart rate, a modest rise in stroke volume, a reduction in peripheral vascular resistance, and an elevation in LV contractile function.",
"   </p>",
"   <p>",
"    The increase in cardiac output must be matched by an increase in left ventricular input. However, increased input cannot be accomplished by the same mechanisms that increase output. As an example, the rise in heart rate that contributes to increased output also shortens the duration of diastole. To balance this and maintain or increase stroke volume, the diastolic filling rate during exercise is normally increased to support the increase in cardiac output.",
"   </p>",
"   <p>",
"    Increased LV filling requires a rise in the rate of diastolic flow across the mitral valve (MV), which in turn requires an increase in the transmitral diastolic pressure gradient. The normal LV permits a remarkable increase in diastolic filling rate during exercise by rapidly and markedly decreasing LV pressure during early diastole, thereby augmenting the left ventricular \"suction\" effect and enhancing the transmitral pressure gradient without increasing LA pressure (",
"    <a class=\"graphic graphic_figure graphicRef51956 \" href=\"UTD.htm?27/58/28576\">",
"     figure 5",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/27-30\">",
"     27-30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Several mechanisms contribute to the enhanced left ventricular diastolic \"suction\" effect during exercise:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The increased contractile function during exercise enhances early diastolic elastic recoil. Thus greater systolic shortening produces a smaller end-systolic volume, which increases elastic recoil and results in enhanced early diastolic filling [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/29\">",
"       29",
"      </a>",
"      ]. Acceleration of myocyte relaxation occurs during exercise, due to an increased rate of calcium uptake by the sarcoplasmic reticulum (SR). Increased cyclic adenosine monophosphate (cAMP), generated by the beta adrenergic response to exercise, leads to phosphorylation of the regulatory SR membrane protein phospholamban to increase the rate of calcium uptake by the SR during diastole [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Some of the mechanisms that effect increases in cardiac output and cardiac input during exercise act in concert on systolic and diastolic function:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The treppe effect describes a relationship between the heart rate (or frequency of contraction), LV pressure (or systolic force development) and ejection fraction (or shortening) such that in a normal heart, an increase in heart rate is associated with an increase in contractility over a physiologic range of heart rates. This has been called the systolic \"force-frequency relationship.\" The same mechanism governs the relationship between heart rate and diastolic relaxation rate where increased heart rate in a normal heart is associated with an increased relaxation rate, which contributes to the maintenance of normal LV diastolic pressures and pulmonary venous pressure during exercise.",
"     </li>",
"     <li>",
"      During exercise in a normal individual, the LV utilizes the Frank-Starling mechanism to augment stroke volume. It is the normal distensibility of the LV that allows an increase in end-diastolic volume with minimal change in late diastolic pressure and no significant change in pulmonary venous pressure.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, the normal heart during exercise has an elegant balance of physiologic mechanisms to ensure that cardiac input keeps pace with cardiac output, with preservation of a low pulmonary capillary pressure. These mechanisms result in an increase in measured LV distensibility, as manifested by a downward shift of the LV diastolic pressure-volume (P-V) curve, especially during early diastole (",
"    <a class=\"graphic graphic_figure graphicRef79248 \" href=\"UTD.htm?17/22/17774\">",
"     figure 6",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. These two mechanisms are impaired in diastolic HF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     MEASUREMENT OF DIASTOLIC FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complete characterization of LV diastolic properties requires simultaneous measurement of pressure and volume. Although some of these measurements can be made using noninvasive methods, invasive assessment with a high-fidelity micromanometer provides the most comprehensive evaluation.",
"   </p>",
"   <p>",
"    Changes in both afterload (systolic pressure) and diastolic load (LA diastolic pressure) can affect measurements of diastolic function. These load-dependent changes do not reflect alteration in intrinsic relaxation properties. Thus, no index of relaxation can be considered an index of \"intrinsic\" relaxation rate unless loading conditions and other modulators are held constant or are at least specified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Rate of isovolumic relaxation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The rate of LV pressure decline, or the rate of isovolumic relaxation, reflects early diastolic function. Accurate assessment requires a high-fidelity micromanometer catheter. Measures of this property include (",
"    <a class=\"graphic graphic_figure graphicRef69433 \" href=\"UTD.htm?12/8/12419\">",
"     figure 7",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Peak (-)",
"      <span class=\"nowrap\">",
"       dP/dt:",
"      </span>",
"      Peak negative",
"      <span class=\"nowrap\">",
"       dP/dt",
"      </span>",
"      is the peak instantaneous rate of LV pressure decline.",
"     </li>",
"     <li>",
"      Tau (&tau;): Tau is the time constant of isovolumic LV pressure decay [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/34\">",
"       34",
"      </a>",
"      ]. When the natural log of LV diastolic pressure is plotted versus time, Tau is the slope of this linear relationship. Stated in more conceptual terms, Tau is the time required for LV pressure to fall by approximately two-thirds of its initial value.",
"     </li>",
"     <li>",
"      Isovolumic relaxation time (IVRT): IVRT can be measured with noninvasive echocardiographic techniques.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    When the relaxation rate is decreased (ie, abnormal diastolic function), Tau is increased and the absolute value of the peak negative",
"    <span class=\"nowrap\">",
"     dP/dt",
"    </span>",
"    is reduced. IVRT increases with impaired relaxation but then decreases with progressive worsening of diastolic function.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Rate and extent of LV filling",
"    </span>",
"    &nbsp;&mdash;&nbsp;The normal LV has a characteristic pattern of filling and transmitral inflow velocities. A number of measures characterize the rate of LV filling, including:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      LV filling rate",
"     </li>",
"     <li>",
"      The time-to-peak-filling rate (TPFR) (",
"      <a class=\"graphic graphic_figure graphicRef59563 \" href=\"UTD.htm?42/33/43538\">",
"       figure 8",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Transmitral flow velocity",
"     </li>",
"     <li>",
"      Diastolic suction (flow propagation velocity)",
"     </li>",
"     <li>",
"      Pulmonary venous flow velocities",
"     </li>",
"     <li>",
"      Myocardial tissue velocity, strain, and strain rate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There are four patterns of diastolic function that can be identified using transmitral Doppler spectral recordings, color Doppler M-mode inflow propagation velocities, pulmonary vein Doppler flow measurements, and tissue Doppler echocardiography: normal, impaired relaxation, pseudonormal, and restrictive (",
"    <a class=\"graphic graphic_waveform graphicRef72146 \" href=\"UTD.htm?31/45/32470\">",
"     waveform 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/35,36\">",
"     35,36",
"    </a>",
"    ]. A description of their hemodynamic basis follows. Echocardiographic evaluation of diastolic function is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/60/33735?source=see_link\">",
"     \"Echocardiographic evaluation of left ventricular diastolic function\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     E and A waves on Doppler echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The E and A waves that quantify peak flow velocities across the mitral valve are among the most commonly used measures of LV relaxation properties. In the normal heart, the rate of LV filling is greatest early in diastole, immediately after mitral valve opening. Similarly, LV inflow velocity across the mitral valve is most rapid in this early phase, reflected by a tall E wave on the transmitral Doppler echocardiogram. This rapid early diastolic filling results from low early diastolic LV pressures, an adequate transmitral early diastolic pressure gradient and significant early diastolic suction (or recoil of stored energy resulting from systolic contraction). Because most LV filling occurs in early and mid diastole, the amount of blood transported by atrial contraction at the end of diastole is relatively small, and the velocity imparted by atrial contraction (the A wave of the transmitral inflow Doppler spectral recording) is also relatively low. Thus, the normal",
"    <span class=\"nowrap\">",
"     E/A",
"    </span>",
"    wave ratio is greater than 1 and approaches a value of 2 in younger individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8876853\">",
"    <span class=\"h3\">",
"     E' and A' on myocardial tissue Doppler echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;LV long-axis lengthening velocity during diastole parallels patterns found in transmitral diastolic inflow. In the normal heart, the rate of lengthening is greatest early in diastole immediately after mitral valve opening, as reflected by a tall E&rsquo;. Lengthening resulting from atrial contraction at the end of diastole is relatively small reflected by a relatively small A&rsquo;.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8876861\">",
"    <span class=\"h2\">",
"     Grades of diastolic dysfunction",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grade I diastolic dysfunction (impaired relaxation): When diastolic dysfunction initially occurs, relaxation is slowed and incomplete as reflected by an increased isovolumic relaxation time. This results in an increase in early LV diastolic pressures, a decrease in the early transmitral pressure gradient, and a decrease in diastolic suction as reflected by a decrease in color M mode flow acceleration (recoil energy lost to abnormal relaxation). LV filling is abnormal with decreased early filling rate and extent, prolonged TPFR, increased filling rate from atrial contraction, and thus, a decreased",
"      <span class=\"nowrap\">",
"       E/A",
"      </span>",
"      ratio (A dominant pattern). Tissue Doppler myocardial lengthening velocity patterns are similar to the transmitral flow velocities, with E&rsquo; reduced and A&rsquo; increased.",
"     </li>",
"     <li>",
"      Grade II diastolic dysfunction (pseudonormal): As diastolic dysfunction progresses, LV filling becomes increasingly dependent upon an increase in LA pressure to push blood into the LV during diastole [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/36\">",
"       36",
"      </a>",
"      ]. As LA pressures rise, the early diastolic transmitral pressure gradient increases, early diastolic flow velocities also rise and the E wave increases, causing the",
"      <span class=\"nowrap\">",
"       E/A",
"      </span>",
"      ratio to increase to a &ldquo;normal&rdquo; (or pseudonormal) value (",
"      <a class=\"graphic graphic_figure graphicRef59563 \" href=\"UTD.htm?42/33/43538\">",
"       figure 8",
"      </a>",
"      ). However, myocardial velocity by tissue Doppler echocardiography is less sensitive to alteration in LV loading conditions than transmitral Doppler velocities and e&rsquo; (the rate of early diastolic myocardial lengthening) remains markedly reduced. Thus, varying combinations of alterations in E and E&rsquo; help to distinguish impaired relaxation and pseudonormal patterns from a normal pattern (",
"      <a class=\"graphic graphic_waveform graphicRef72146 \" href=\"UTD.htm?31/45/32470\">",
"       waveform 1",
"      </a>",
"      ). Impaired relaxation is associated with a low",
"      <span class=\"nowrap\">",
"       E/e&rsquo;",
"      </span>",
"      ratio, a pseudonormal pattern is associated with a normal or increased",
"      <span class=\"nowrap\">",
"       E/e&rsquo;",
"      </span>",
"      since e&rsquo; is abnormally low. In addition, combined E and e&rsquo; data can be used to estimate PCWP [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/37\">",
"       37",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/60/33735?source=see_link\">",
"       \"Echocardiographic evaluation of left ventricular diastolic function\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Grades III and IV diastolic dysfunction (restrictive): If left atrial pressures are severely increased, a \"restrictive\" pattern may develop in which the isovolumic relaxation time may be decreased, transmitral pressure gradient is further increased and the",
"      <span class=\"nowrap\">",
"       E/A",
"      </span>",
"      and",
"      <span class=\"nowrap\">",
"       E/E&rsquo;",
"      </span>",
"      ratios are markedly increased to supernormal levels [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/21\">",
"       21",
"      </a>",
"      ]. This restrictive pattern is characteristic of marked elevations in filling pressure with grade III (reversible restrictive pattern) or IV (irreversible restrictive pattern) diastolic dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/36\">",
"       36",
"      </a>",
"      ]. A variety of conditions may cause a restrictive filling pattern. Of note, a restrictive filling pattern is not equivalent to and is not a specific sign of restrictive cardiomyopathy, although restrictive cardiomyopathy is one of the many conditions that can cause this pattern.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Passive elastic stiffness properties",
"    </span>",
"    &nbsp;&mdash;&nbsp;LV diastolic stiffness and distensibility are quantified by the position and shape of the LV diastolic pressure-volume (P-V) relationship displayed as a plot of LV pressure and volume throughout diastole (",
"    <a class=\"graphic graphic_figure graphicRef68133 \" href=\"UTD.htm?19/32/19982\">",
"     figure 9",
"    </a>",
"    ). A relatively stiff, nondistensible ventricle will require higher pressures to achieve a given volume. Thus, an increase in LV diastolic chamber stiffness (or decrease in distensibility) shifts the diastolic P-V curve upwards, and often also increases its slope. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=see_link\">",
"     \"Pathophysiology of heart failure: Left ventricular pressure-volume relationships\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Defining the entire LV filling curve throughout diastole requires the simultaneous measurement of diastolic pressure and volume. This can be done either throughout a single cardiac cycle (to define the diastolic pressure versus volume relationship) or by measuring the end-diastolic pressure-volume coordinate over a series of variably loaded cardiac cycles (to define the end-diastolic pressure versus volume relationship).",
"   </p>",
"   <p>",
"    Volume measurements can be made by angiography, echocardiography, or radionuclide imaging techniques. Simultaneous measurements of LV diastolic pressure are usually made invasively. Alternatively, noninvasive Doppler echocardiographic techniques can be used to estimate pulmonary capillary wedge pressure (PCWP). Together with echocardiographically measured end-diastolic volume (EDV), an index of instantaneous diastolic stiffness",
"    <span class=\"nowrap\">",
"     (PCWP/EDV",
"    </span>",
"    ratio) can be derived [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     ABNORMAL CARDIOVASCULAR STRUCTURE AND FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;DHF is typically associated with significant remodeling that affects the left ventricular (LV) and left atrial (LA) chambers, the cardiomyocytes and the extracellular matrix (",
"    <a class=\"graphic graphic_table graphicRef55386 \" href=\"UTD.htm?9/55/10109\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Structural abnormalities",
"    </span>",
"    &nbsp;&mdash;&nbsp;The structural remodeling that occurs in DHF differs dramatically from that in SHF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Chamber remodeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many, but not all, patients with DHF exhibit a concentric pattern of LV remodeling and a hypertrophic process that is characterized by the following features (",
"    <a class=\"graphic graphic_figure graphicRef87847 \" href=\"UTD.htm?17/60/18371\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/1,2,6,8,39-43\">",
"     1,2,6,8,39-43",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A normal or near-normal end-diastolic volume",
"     </li>",
"     <li>",
"      Increased wall thickness",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      LV mass",
"     </li>",
"     <li>",
"      An increased ratio of myocardial mass to cavity volume",
"     </li>",
"     <li>",
"      An increased relative wall thickness (RWT). The RWT is defined as either 2 X (posterior wall",
"      <span class=\"nowrap\">",
"       thickness)/(LV",
"      </span>",
"      diastolic diameter)",
"      <strong>",
"       or",
"      </strong>",
"      as (septal wall thickness + posterior wall",
"      <span class=\"nowrap\">",
"       thickness)/(LV",
"      </span>",
"      diastolic diameter).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Studies have demonstrated that over 95 percent of patients with diastolic HF have a normal LV end diastolic volume; 50 to 66 percent have an increased wall thicknesses, mass and relative wall thickness [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/41-43\">",
"     41-43",
"    </a>",
"    ]. These patients commonly have hypertensive heart disease which leads to concentric remodeling, cardiomyocyte hypertrophy and increased extracellular matrix that result in diastolic dysfunction and increased chamber stiffness. However, hypertensive heart disease and concentric remodeling are not the only causes of these abnormalities. For example, diabetic heart disease, coronary artery disease, and advanced age even in the absence of LV hypertrophy, can result in diastolic dysfunction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28569?source=see_link\">",
"     \"Heart failure in diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By contrast, patients with SHF exhibit a pattern of eccentric remodeling with an increase in end-diastolic volume, an increase in LV mass but little increase in wall thickness, and a substantial decrease in the ratio of mass to volume and thickness to radius [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/1,2,6,8,39,40\">",
"     1,2,6,8,39,40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Cardiomyocyte and extracellular matrix remodeling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Alterations in organ morphology and geometry are generally paralleled by differences at the microscopic level. In DHF, the cardiomyocyte exhibits an increased diameter with little or no change in cardiomyocyte length, corresponding to the increase in LV wall thickness with no change in LV volume. By contrast, in SHF the cardiomyocytes are elongated with little or no change in diameter, corresponding to the increase in LV volume with no change in LV wall thickness.",
"   </p>",
"   <p>",
"    In DHF, there is an increase in the amount of collagen with a corresponding increment in the width and continuity of the fibrillar components of the extracellular matrix [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/2,39,40\">",
"     2,39,40",
"    </a>",
"    ]. There is also serologic evidence of an active fibrotic process in the myocardium of patients with DHF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/44\">",
"     44",
"    </a>",
"    ]. In SHF, there is degradation and disruption of the fibrillar collagen, at least early in the development of SHF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/2,39,40\">",
"     2,39,40",
"    </a>",
"    ]. In end-stage SHF, replacement fibrosis and regional ischemic scarring may result in an overall increase in fibrillar collagen within the extracellular matrix.",
"   </p>",
"   <p>",
"    A detailed discussion of the cellular mechanisms of diastolic dysfunction is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/38/30313?source=see_link\">",
"     \"Cellular mechanisms of diastolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Diastolic dysfunction in DHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;In DHF, abnormalities in diastolic function form the dominant pathophysiologic basis for the development of the clinical syndrome of HF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/4-8,35,38-40\">",
"     4-8,35,38-40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The major abnormalities in LV diastolic function are:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Slowed, delayed and incomplete myocardial relaxation",
"     </li>",
"     <li>",
"      Impaired rate and extent of LV filling",
"     </li>",
"     <li>",
"      Shift of filling from early to late diastole",
"     </li>",
"     <li>",
"      Increased dependence on LV filling from atrial contraction",
"     </li>",
"     <li>",
"      Decreased early diastolic",
"      <span class=\"nowrap\">",
"       suction/recoil",
"      </span>",
"     </li>",
"     <li>",
"      Increased LA pressure during the early filling",
"     </li>",
"     <li>",
"      Increased passive stiffness and decreased distensibility of the LV",
"     </li>",
"     <li>",
"      Impaired ability to augment cardiac output during exercise",
"     </li>",
"     <li>",
"      Reduced ability to augment relaxation during exercise",
"     </li>",
"     <li>",
"      Limited ability to utilize the Frank-Starling mechanism during exercise",
"     </li>",
"     <li>",
"      Increased diastolic LV, LA, pulmonary venous pressure at rest",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      during exercise.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In a given patient, impairment in one or more of these parameters will result in decreased LV chamber distensibility and an increase in diastolic pressure at any given LV volume. When myocardial relaxation is impaired, the rate and amount of early diastolic LV filling are reduced. This reduction requires a relative shift of LV filling to the later part of diastole, with atrial contraction making a more important contribution to ventricular filling than in normal subjects. The redistribution of filling from early to late diastole makes patients with diastolic dysfunction more sensitive than normal individuals to the effects of tachycardia and loss of atrial contraction, such as occurs with atrial fibrillation. An increase in heart rate shortens the duration of diastole and truncates the important late phase of diastolic filling.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19796955\">",
"    <span class=\"h3\">",
"     Exacerbation of diastolic dysfunction during exercise",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in diastolic function become exaggerated during exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/45-47\">",
"     45-47",
"    </a>",
"    ]. As noted above, complex changes in diastolic properties are required to increase LV filling in parallel with LV output during periods of exercise. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Normal response to exercise'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Increased heart rates and cardiac output during exercise require more rapid LV filling. Normally, this is accomplished by accelerated LV relaxation, which lowers LV diastolic pressures and increases the LA-LV pressure gradient. Patients with diastolic dysfunction are not able to increase the rate of LV relaxation as necessary to lower LV diastolic pressure and allow more rapid early diastolic filling. Instead, early diastolic filling is increased by an elevation in LA pressure. The increase in LA pressure results in pulmonary congestion with exercise, a hallmark of DHF (",
"    <a class=\"graphic graphic_figure graphicRef51956 \" href=\"UTD.htm?27/58/28576\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In addition, patients with DHF are unable to increase LV end-diastolic volume and recruit Frank-Starling forces. As a result, there is a limited ability to increase cardiac output. In conjunction with increased pulmonary pressures, this results in a marked truncation of exercise capacity. These abnormal responses to exercise are made worse by the exaggerated increase in arterial blood pressure that frequently accompanies exercise in patients with DHF.",
"   </p>",
"   <p>",
"    Abnormal diastolic function also plays a role in exercise intolerance suffered by patients with SHF. In SHF, systolic dysfunction causes the left ventricle to lose the ability to augment diastolic filling in response to exercise by the normal mechanism of accentuated elastic recoil and early diastolic suction described above [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/27-29\">",
"     27-29",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Physiology of left ventricular diastole'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Decompensated DHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal LV diastolic function is a universal finding in patients with DHF. Even when clinically compensated, patients with DHF have evidence of diastolic dysfunction, with abnormal relaxation, filling, and stiffness and increased diastolic pressures. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Measurement of diastolic function'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Further changes in diastolic function occur when patients develop decompensated DHF [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/48-51\">",
"     48-51",
"    </a>",
"    ]. Decompensation into overt HF is associated with further changes in diastolic relaxation and filling patterns that reduce LV distensibility. The LV diastolic pressure volume (P-V) relationship is shifted upwards and pulmonary congestion and exercise intolerance may ensue. Alternately, decompensation may be triggered by increases in intravascular volume. These volume-dependent increases in LV diastolic pressure occur along an already steep diastolic pressure-volume curve, and may induce pulmonary congestion without a change in the position or shape of the diastolic pressure-volume curve. Recent studies have demonstrated that slow and progressive increases in LV diastolic filling pressures often occur over days to weeks preceding any changes in symptoms of signs of HF (",
"    <a class=\"graphic graphic_figure graphicRef51124 \" href=\"UTD.htm?18/30/18927\">",
"     figure 10",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/43,50\">",
"     43,50",
"    </a>",
"    ]. Thus, during the transition from compensated to decompensated diastolic HF, pathophysiologic changes in diastolic pressure often occur well in advance of the development of clinical symptoms. Because the clinical manifestations of decompensated HF occur late in this transition process and with apparent rapid onset of symptoms, the term &ldquo;acute&rdquo; is often added to the term &ldquo;decompensated HF.&rdquo; However, while the symptoms of decompensation present acutely, the pathophysiologic processes that underlie the transition from compensated to decompensated HF do not occur acutely.",
"   </p>",
"   <p>",
"    Decompensated DHF may be caused by both cardiovascular and noncardiovascular factors (or \"triggers\"). Such triggers act on preexisting structural and functional abnormalities to precipitate the development of acute decompensated HF. As examples, atrial fibrillation, tachycardia, or uncontrolled hypertension can lead to rapid increases in LA pressures. The abrupt rise in LA pressure causes a significant change in transmitral Doppler flow pattern, and may result in &ldquo;pseudonormalization.&rdquo; (See",
"    <a class=\"local\" href=\"#H13\">",
"     'E and A waves on Doppler echocardiography'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Potential triggers for decompensated DHF include [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/1,15,52-58\">",
"     1,15,52-58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Uncontrolled hypertension",
"     </li>",
"     <li>",
"      Increased salt and water intake",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      retention",
"     </li>",
"     <li>",
"      Tachyarrhythmias",
"     </li>",
"     <li>",
"      Ischemia",
"     </li>",
"     <li>",
"      Chronic kidney disease",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"     <li>",
"      Chronic lung disease",
"     </li>",
"     <li>",
"      Infection",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These comorbidities act upon the substrate to precipitate acute decompensated DHF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Systolic function in DHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;By definition, the left ventricular ejection fraction (LVEF) and most indices of contractile function are normal or nearly normal in patients with DHF (",
"    <a class=\"graphic graphic_table graphicRef55386 \" href=\"UTD.htm?9/55/10109\">",
"     table 2",
"    </a>",
"    ). This issue was directly assessed in a study in which the systolic properties of the left ventricle were evaluated by echocardiography and cardiac catheterization in 75 patients with diastolic heart failure and 75 normal controls [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/8\">",
"     8",
"    </a>",
"    ]. There was no difference between the two groups in a variety of measures of LV systolic performance, such as stroke work, the relationship between stroke work and end-diastolic volume, and the peak positive",
"    <span class=\"nowrap\">",
"     dP/dt.",
"    </span>",
"    Thus, the pathophysiology of diastolic HF does not appear to be associated with significant abnormalities in systolic function or contractility [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, in several series (including the study mentioned above), sophisticated imaging techniques (eg, tissue Doppler imaging) have identified abnormalities of regional systolic function in approximately 30 to 50 percent of patients with diastolic dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/2,59-62\">",
"     2,59-62",
"    </a>",
"    ]. These abnormalities are usually noted in longitudinal contraction and motion of the basal left ventricle in the region of the mitral annulus. The clinical significance of these abnormalities is unclear since many patients with hypertensive heart disease who do not have HF also have these abnormalities.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Dyssynchrony in DHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;The prevalence of systolic and diastolic dyssynchrony in patients with DHF was assessed in two observational series [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/63,64\">",
"     63,64",
"    </a>",
"    ]. Using TDI, systolic and diastolic dyssynchrony were noted in 33 to 39 percent and 36 to 58 percent of DHF patients, respectively. This prevalence is similar to that observed in patients with systolic HF. However, whether or not dyssynchrony is an important contributor to the pathophysiology of DHF remains uncertain.",
"   </p>",
"   <p>",
"    In selected patients with HF due to systolic dysfunction, treatment of dyssynchrony with cardiac resynchronization therapy (CRT) with biventricular (BiV) pacing can improve both symptoms and survival (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=see_link\">",
"     \"Cardiac resynchronization therapy in heart failure: Indications\"",
"    </a>",
"    ). CRT has not been shown to benefit patients with DHF.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MECHANISMS BY WHICH CARDIAC DISEASES CAUSE DHF",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of cardiac diseases can cause the development of abnormal diastolic function. The two most common pathways are ischemia and left ventricular hypertrophy.",
"   </p>",
"   <p>",
"    Cardiovascular disorders that lead to DHF include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coronary artery disease and myocardial ischemia.",
"     </li>",
"     <li>",
"      Chronic hypertension with concentric remodeling. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=see_link\">",
"       \"Clinical implications and treatment of left ventricular hypertrophy in hypertension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Valvular aortic stenosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=see_link\">",
"       \"Clinical features and evaluation of aortic stenosis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypertrophic cardiomyopathy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28600?source=see_link\">",
"       \"Types and pathophysiology of obstructive hypertrophic cardiomyopathy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=see_link\">",
"       \"Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These mechanisms can act individually to alter diastolic function but often act in concert to cause the development of DHF. For ease of understanding, these mechanisms will first be discussed individually.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia can cause a reversible impairment in myocyte relaxation and diastolic function. The resultant slowing or failure of myocyte relaxation causes a fraction of actin-myosin crossbridges to persist and continue to generate tension throughout diastole, especially in early diastole, creating a state of \"partial persistent systole.\"",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25082686\">",
"    <span class=\"h3\">",
"     Two types of ischemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia can alter diastolic function by two separate mechanisms: demand ischemia, created by an increase in energy utilization that outstrips the available supply; and supply ischemia, created by a primary decrease in myocardial blood flow.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Demand ischemia &mdash; Demand ischemia typically occurs during exercise or pharmacologically induced stress. It results from an increase in oxygen demand in the setting of limited coronary flow reserve due to a coronary stenosis",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      ventricular hypertrophy. During demand ischemia, diastolic dysfunction may be related to myocardial ATP depletion, a decrease in free energy release from ATP hydrolysis and a concomitant increase in ADP [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/65,66\">",
"       65,66",
"      </a>",
"      ], resulting in rigor (rigor bond formation) [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/65,67\">",
"       65,67",
"      </a>",
"      ]. Although ischemia is also associated with persistence of an increased intracellular calcium concentration during diastole, it is not clear if elevated calcium levels contribute directly to diastolic dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/68\">",
"       68",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10632?source=see_link\">",
"       \"Excitation-contraction coupling in myocardium\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      As a result of rigor, LV pressure decay, as assessed by tau, is impaired and the LV is stiffer than normal during diastole. This will result in retardation of LV filling and increased diastolic pressures [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/69\">",
"       69",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Supply ischemia &mdash; Supply ischemia results from a marked reduction in coronary flow. The net effect is inadequate coronary perfusion even in the resting state. In experimental models, acute supply ischemia causes an initial transient downward and rightward shift of the diastolic P-V curve such that end-diastolic volume increases relative to end-diastolic pressure, indicating a \"paradoxical\" increase in diastolic compliance [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/70\">",
"       70",
"      </a>",
"      ]. By contrast, during demand ischemia, diastolic compliance falls acutely [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/70-72\">",
"       70-72",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These opposite initial compliance changes with demand and supply ischemia may be explained by differences in the pressure and volume within the coronary vasculature, by the mechanical effects of the normal myocardium adjacent to the ischemic region, and by tissue metabolic factors. The differences between supply and demand ischemia are transient. After more sustained ischemia of 30 to 60 minutes or longer, both types result in decreased diastolic compliance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Ischemia and pulmonary symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemia, either spontaneous or during exercise, prevents the normal increase in LV distensibility and can also cause a rapid and marked increase in LV diastolic chamber stiffness. LV diastolic pressures quickly increase, resulting in acute pulmonary congestion (",
"    <a class=\"graphic graphic_figure graphicRef71811 \" href=\"UTD.htm?31/22/32109\">",
"     figure 11",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef75413 \" href=\"UTD.htm?32/23/33151\">",
"     figure 12",
"    </a>",
"    ). This upward shift of the left ventricular diastolic P-V curve is completely reversible with recovery of myocardial perfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The effects of ischemia explain why many patients with coronary disease have respiratory symptoms with their anginal pain, including wheezing, an inability to take a deep breath, or shortness of breath. Such respiratory symptoms may occur in the absence of anginal pain and are often referred to as \"anginal equivalents.\" (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=see_link\">",
"     \"Pathophysiology and clinical presentation of ischemic chest pain\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    These respiratory symptoms are similar to those of HF, which is not surprising since the responsible mechanism is an elevation in pulmonary venous pressure. One study, for example, showed that the acute decrease in left ventricular distensibility and increase in diastolic pressure during angina caused an increase in airway resistance and a reduction in lung compliance [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/73\">",
"     73",
"    </a>",
"    ]. A similar symptom complex may occur in patients with concentric LVH during exercise even in the absence of epicardial CAD. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'LV concentric hypertrophy'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Reperfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ischemic diastolic dysfunction can continue after normal myocardial blood flow has been reestablished (ie, reperfusion). This phenomenon has been noted both after cardiac surgery and after primary reperfusion therapy for an acute myocardial infarction under circumstances of prolonged ischemia (more than 90 to 120 minutes) [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/74-76\">",
"     74-76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Postischemic mechanical dysfunction results in both systolic and diastolic dysfunction, and the latter may be a more sensitive parameter of ischemic injury [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/70\">",
"     70",
"    </a>",
"    ]. During reperfusion, LV diastolic chamber stiffness is increased [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. Over time, diastolic dysfunction resolves and it is therefore reasonable to refer to this process as postischemic diastolic stunning. Recognition of this phenomenon is important because a reduced cardiac output or elevated pulmonary capillary wedge pressure in the early postoperative period or early after treatment of acute coronary syndrome may reflect an increase in LV diastolic chamber stiffness rather than a reduction in contractile function. This distinction can be made readily with echocardiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     LV concentric hypertrophy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Widespread use of noninvasive methods of cardiac imaging has led to the recognition that LV diastolic dysfunction and DHF are commonly induced by the myocardial hypertrophy associated with hypertensive, coronary, or valvular heart disease. The resistance to diastolic filling is usually the result of common structural abnormalities including concentric LV remodeling, cardiomyocyte hypertrophy, altered extracellular matrix structure and composition, and increased fibrillar collagen. All of these hypertrophy-associated changes lead to impaired cellular and myocardial relaxation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/38/30313?source=see_link\">",
"     \"Cellular mechanisms of diastolic dysfunction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Left ventricular hypertrophy (LVH) and ischemia have important interactions; for a given degree of ischemia; a greater decline in diastolic function is seen in hypertrophied hearts [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/6,77\">",
"     6,77",
"    </a>",
"    ]. Hearts with concentric LVH are highly susceptible to subendocardial ischemia for several reasons [",
"    <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/78\">",
"     78",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is some evidence of inadequate coronary growth relative to muscle mass, with a resultant decrease in capillary density [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/79\">",
"       79",
"      </a>",
"      ]. The ensuing increase in capillary to myocyte oxygen diffusion distance renders the hypertrophied myocyte more susceptible to ischemia.",
"     </li>",
"     <li>",
"      The increase in ventricular wall thickness raises the epicardial-endocardial distance. The coronary arterial circulation consists of epicardial vessels, which penetrate transmurally, giving rise to mid-myocardial branches, which perfuse the thickened left ventricular wall before supplying the subendocardium. Thus, coronary perfusion pressure is dissipated in proportion to left ventricular wall thickness, leaving the subendocardium as the region most vulnerable to ischemia [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Coronary arterial remodeling accompanies concentric hypertrophy and is manifested by an increase in coronary arterial medial thickness and perivascular fibrosis, which can restrict the extent of coronary arterial vasodilatation.",
"     </li>",
"     <li>",
"      Vascular tone at rest is often abnormally reduced and coronary flow at rest is increased in the hypertrophied heart [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/80,81\">",
"       80,81",
"      </a>",
"      ]. Enhanced coronary flow is required in the resting state to supply the increased muscle mass. However, since maximal achievable coronary flow is similar to that of normal ventricles, coronary flow reserve is diminished. Endothelial dysfunction also may contribute to the reduction in coronary reserve, although the response to exogenous nitric oxide is preserved [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/82,83\">",
"       82,83",
"      </a>",
"      ]. Thus, when metabolic demand and the need for oxygen increases, coronary reserve is often inadequate to meet the increased oxygen requirements, and ischemia ensues [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/81\">",
"       81",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Increased left ventricular diastolic pressures can cause vascular compression, thereby reducing coronary flow and perfusion of the subendocardial layer [",
"      <a class=\"abstract\" href=\"UTD.htm?15/28/15818/abstract/78\">",
"       78",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The incidence and severity of coronary atherosclerosis is increased in the presence of systemic arterial hypertension, a frequent cause of concentric LVH. Thus, patients with concentric LVH on a hypertensive basis often have significant concomitant coronary artery disease.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These factors make the heart with concentric LVH exquisitely sensitive to subendocardial ischemia.",
"   </p>",
"   <p>",
"    The hypertrophied ventricle also cannot relax normally in diastole with exercise. Thus, to produce the necessary increase in ventricular filling, there is an increase in left atrial pressure. Increased left atrial pressure and pulmonary venous pressure can contribute to dyspnea and even lead to pulmonary congestion. Exercise-induced subendocardial ischemia can exacerbate impairment of diastolic relaxation of the hypertrophied myocardium.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2111553\">",
"    <span class=\"h1\">",
"     ASSOCIATION WITH OBSTRUCTIVE SLEEP APNEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diastolic dysfunction is commonly associated with obstructive sleep apnea (OSA). In a study of 378 subjects with risk factors for diastolic dysfunction (hypertension, atherosclerotic disease, or signs or symptoms of heart failure) with mean age 66 years, 22 percent had moderate to severe OSA, 40 percent had mild OSA, and 39 percent had no OSA.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13956?source=see_link\">",
"       \"Patient information: Diastolic heart failure (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13107298\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Diastolic dysfunction and diastolic heart failure (DHF) are not synonymous. The term diastolic HF is reserved for patients with clinical HF, in the setting of a normal or near-normal EF, and abnormalities in diastolic function. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Diastolic dysfunction versus DHF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The key distinguishing feature between systolic and diastolic HF is whether the ejection fraction is reduced (indicating systolic HF) or preserved, meaning normal or near-normal (indicating diastolic HF). Diastolic dysfunction is not the only cause of HF in patients with preserved LVEF (",
"      <a class=\"graphic graphic_table graphicRef54975 \" href=\"UTD.htm?19/7/19580\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Systolic versus diastolic HF'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diastole begins with isovolumic relaxation followed by auxotonic relaxation and continues until atrial contraction is complete. During the later phases of diastolic HF, the LV is readily distensible. Atrial contraction normally contributes 20 to 30 percent to total LV filling volume but usually increases diastolic pressures by less than 5 mmHg. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Events during diastole'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      During exercise, physiologic mechanisms normally ensure that cardiac input keeps pace with cardiac output with preservation of a low pulmonary venous pressure. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Normal response to exercise'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Since both afterload (systolic pressure) and diastolic load (left atrial diastolic pressure) can affect measurement of diastolic function, these factors must be considered in assessing the intrinsic relaxation rate. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Measurement of diastolic function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      DHF is associated with remodeling that affects left ventricular and left atrial chambers, the cardiomyocytes, and extracellular matrix with impact on diastolic as well as systolic function. Nearly all patients with diastolic HF have a normal LV end diastolic volume; most have increased LV wall thicknesses, mass and relative wall thickness. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Abnormal cardiovascular structure and function'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two most common pathways to DHF are left ventricular hypertrophy and ischemia. (See",
"      <a class=\"local\" href=\"#H24\">",
"       'Mechanisms by which cardiac diseases cause DHF'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/1\">",
"      Qui&ntilde;ones MA, Zile MR, Massie BM, et al. Chronic heart failure: a report from the Dartmouth Diastole Discourses. Congest Heart Fail 2006; 12:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/2\">",
"      Aurigemma GP, Zile MR, Gaasch WH. Contractile behavior of the left ventricle in diastolic heart failure: with emphasis on regional systolic function. Circulation 2006; 113:296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/3\">",
"      Drazner MH. The progression of hypertensive heart disease. Circulation 2011; 123:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/4\">",
"      Zile MR, Gaasch WH, Carroll JD, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation 2001; 104:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/5\">",
"      Zile MR. Heart failure with preserved ejection fraction: is this diastolic heart failure? J Am Coll Cardiol 2003; 41:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/6\">",
"      Aurigemma GP, Gaasch WH. Clinical practice. Diastolic heart failure. N Engl J Med 2004; 351:1097.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/7\">",
"      Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure--abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004; 350:1953.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/8\">",
"      Baicu CF, Zile MR, Aurigemma GP, Gaasch WH. Left ventricular systolic performance, function, and contractility in patients with diastolic heart failure. Circulation 2005; 111:2306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/9\">",
"      Little WC, Zile MR. HFpEF: cardiovascular abnormalities not just comorbidities. Circ Heart Fail 2012; 5:669.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/10\">",
"      Lee DS, Gona P, Vasan RS, et al. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Circulation 2009; 119:3070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/11\">",
"      Paulus WJ, van Ballegoij JJ. Treatment of heart failure with normal ejection fraction: an inconvenient truth! J Am Coll Cardiol 2010; 55:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/12\">",
"      Gaasch WH, Delorey DE, Kueffer FJ, Zile MR. Distribution of left ventricular ejection fraction in patients with ischemic and hypertensive heart disease and chronic heart failure. Am J Cardiol 2009; 104:1413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/13\">",
"      Desai RV, Ahmed MI, Mujib M, et al. Natural history of concentric left ventricular geometry in community-dwelling older adults without heart failure during seven years of follow-up. Am J Cardiol 2011; 107:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/14\">",
"      Rame JE, Ramilo M, Spencer N, et al. Development of a depressed left ventricular ejection fraction in patients with left ventricular hypertrophy and a normal ejection fraction. Am J Cardiol 2004; 93:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/15\">",
"      Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/16\">",
"      Redfield MM, Jacobsen SJ, Burnett JC Jr, et al. Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 2003; 289:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/17\">",
"      Kitzman DW, Little WC, Brubaker PH, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA 2002; 288:2144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/18\">",
"      Brucks S, Little WC, Chao T, et al. Contribution of left ventricular diastolic dysfunction to heart failure regardless of ejection fraction. Am J Cardiol 2005; 95:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/19\">",
"      Gaasch WH, Delorey DE, St John Sutton MG, Zile MR. Patterns of structural and functional remodeling of the left ventricle in chronic heart failure. Am J Cardiol 2008; 102:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/20\">",
"      Zile MR, Gaasch WH, Anand IS, et al. Mode of death in patients with heart failure and a preserved ejection fraction: results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-Preserve) trial. Circulation 2010; 121:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/21\">",
"      Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 2003; 362:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/22\">",
"      Ahmed A, Rich MW, Fleg JL, et al. Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial. Circulation 2006; 114:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/23\">",
"      Cleland JG, Tendera M, Adamus J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J 2006; 27:2338.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/24\">",
"      Massie BM, Carson PE, McMurray JJ, et al. Irbesartan in patients with heart failure and preserved ejection fraction. N Engl J Med 2008; 359:2456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/25\">",
"      van Veldhuisen DJ, Cohen-Solal A, B&ouml;hm M, et al. Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). J Am Coll Cardiol 2009; 53:2150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/26\">",
"      Zile MR, Baicu CF, Bonnema DD. Diastolic heart failure: definitions and terminology. Prog Cardiovasc Dis 2005; 47:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/27\">",
"      Cheng CP, Igarashi Y, Little WC. Mechanism of augmented rate of left ventricular filling during exercise. Circ Res 1992; 70:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/28\">",
"      Cheng CP, Noda T, Nozawa T, Little WC. Effect of heart failure on the mechanism of exercise-induced augmentation of mitral valve flow. Circ Res 1993; 72:795.",
"     </a>",
"    </li>",
"    <li>",
"     Little WC, Cheng CP. Modulation of diastolic dysfunction in the intact heart. In: Diastolic Relaxation of the Heart, 2nd ed, Lorell BH, Grossman W (Eds), Kluwer Academic Publishers, Boston 1994. p.167.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/30\">",
"      Little WC. Diastolic dysfunction beyond distensibility: adverse effects of ventricular dilatation. Circulation 2005; 112:2888.",
"     </a>",
"    </li>",
"    <li>",
"     Katz AM. Physiology of the Heart, Raven Press, New York 1992. p.178.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/32\">",
"      Carroll JD, Hess OM, Hirzel HO, Krayenbuehl HP. Dynamics of left ventricular filling at rest and during exercise. Circulation 1983; 68:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/33\">",
"      Carroll JD, Hess OM, Hirzel HO, Krayenbuehl HP. Exercise-induced ischemia: the influence of altered relaxation on early diastolic pressures. Circulation 1983; 67:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/34\">",
"      Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function. Circulation 2002; 105:1387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/35\">",
"      Oh JK, Hatle L, Tajik AJ, Little WC. Diastolic heart failure can be diagnosed by comprehensive two-dimensional and Doppler echocardiography. J Am Coll Cardiol 2006; 47:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/36\">",
"      Lester SJ, Tajik AJ, Nishimura RA, et al. Unlocking the mysteries of diastolic function: deciphering the Rosetta Stone 10 years later. J Am Coll Cardiol 2008; 51:679.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/37\">",
"      Nagueh SF, Mikati I, Kopelen HA, et al. Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging. Circulation 1998; 98:1644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/38\">",
"      Ahmed SH, Clark LL, Pennington WR, et al. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease. Circulation 2006; 113:2089.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/39\">",
"      Borb&eacute;ly A, van der Velden J, Papp Z, et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005; 111:774.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/40\">",
"      van Heerebeek L, Borb&eacute;ly A, Niessen HW, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006; 113:1966.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/41\">",
"      Persson H, Lonn E, Edner M, et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES. J Am Coll Cardiol 2007; 49:687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/42\">",
"      Lam CS, Roger VL, Rodeheffer RJ, et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation 2007; 115:1982.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/43\">",
"      Melenovsky V, Borlaug BA, Rosen B, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol 2007; 49:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/44\">",
"      Martos R, Baugh J, Ledwidge M, et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007; 115:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/45\">",
"      Little WC, Zile MR, Klein A, et al. Effect of losartan and hydrochlorothiazide on exercise tolerance in exertional hypertension and left ventricular diastolic dysfunction. Am J Cardiol 2006; 98:383.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/46\">",
"      Warner JG Jr, Metzger DC, Kitzman DW, et al. Losartan improves exercise tolerance in patients with diastolic dysfunction and a hypertensive response to exercise. J Am Coll Cardiol 1999; 33:1567.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/47\">",
"      Little WC, Wesley-Farrington DJ, Hoyle J, et al. Effect of candesartan and verapamil on exercise tolerance in diastolic dysfunction. J Cardiovasc Pharmacol 2004; 43:288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/48\">",
"      Gandhi SK, Powers JC, Nomeir AM, et al. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/49\">",
"      Vinch CS, Aurigemma GP, Hill JC, et al. Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol 2003; 91:1140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/50\">",
"      Zile MR, Bourge RC, Bennett TD, et al. Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial. J Card Fail 2008; 14:816.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/51\">",
"      Zile MR, Bennett TD, St John Sutton M, et al. Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 2008; 118:1433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/52\">",
"      Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006; 355:251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/53\">",
"      Yancy CW, Lopatin M, Stevenson LW, et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J Am Coll Cardiol 2006; 47:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/54\">",
"      Brucks S, Little WC, Chao T, et al. Relation of anemia to diastolic heart failure and the effect on outcome. Am J Cardiol 2004; 93:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/55\">",
"      Fukuta H, Sane DC, Brucks S, Little WC. Statin therapy may be associated with lower mortality in patients with diastolic heart failure: a preliminary report. Circulation 2005; 112:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/56\">",
"      O'Meara E, Clayton T, McEntegart MB, et al. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation 2006; 113:986.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/57\">",
"      Zile MR. Treating diastolic heart failure with statins: \"phat\" chance for pleiotropic benefits. Circulation 2005; 112:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/58\">",
"      Katz AM, Zile MR. New molecular mechanism in diastolic heart failure. Circulation 2006; 113:1922.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/59\">",
"      Yu CM, Lin H, Yang H, et al. Progression of systolic abnormalities in patients with \"isolated\" diastolic heart failure and diastolic dysfunction. Circulation 2002; 105:1195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/60\">",
"      Yip G, Wang M, Zhang Y, et al. Left ventricular long axis function in diastolic heart failure is reduced in both diastole and systole: time for a redefinition? Heart 2002; 87:121.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/61\">",
"      Petrie MC, Caruana L, Berry C, McMurray JJ. \"Diastolic heart failure\" or heart failure caused by subtle left ventricular systolic dysfunction? Heart 2002; 87:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/62\">",
"      Nikitin NP, Witte KK, Clark AL, Cleland JG. Color tissue Doppler-derived long-axis left ventricular function in heart failure with preserved global systolic function. Am J Cardiol 2002; 90:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/63\">",
"      Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol 2007; 49:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/64\">",
"      Yu CM, Zhang Q, Yip GW, et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J Am Coll Cardiol 2007; 49:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/65\">",
"      Tian R, Christe ME, Spindler M, et al. Role of MgADP in the development of diastolic dysfunction in the intact beating rat heart. J Clin Invest 1997; 99:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/66\">",
"      Cave AC, Ingwall JS, Friedrich J, et al. ATP synthesis during low-flow ischemia: influence of increased glycolytic substrate. Circulation 2000; 101:2090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/67\">",
"      Saupe KW, Eberli FR, Ingwall JS, Apstein CS. Metabolic support as an adjunct to inotropic support in the hypoperfused heart. J Mol Cell Cardiol 2001; 33:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/68\">",
"      Eberli FR, Str&ouml;mer H, Ferrell MA, et al. Lack of direct role for calcium in ischemic diastolic dysfunction in isolated hearts. Circulation 2000; 102:2643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/69\">",
"      Steine K, Stugaard M, Smiseth OA. Mechanisms of retarded apical filling in acute ischemic left ventricular failure. Circulation 1999; 99:2048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/70\">",
"      Apstein CS, Grossman W. Opposite initial effects of supply and demand ischemia on left ventricular diastolic compliance: the ischemia-diastolic paradox. J Mol Cell Cardiol 1987; 19:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/71\">",
"      Varma N, Eberli FR, Apstein CS. Increased diastolic chamber stiffness during demand ischemia: response to quick length change differentiates rigor-activated from calcium-activated tension. Circulation 2000; 101:2185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/72\">",
"      Varma N, Eberli FR, Apstein CS. Left ventricular diastolic dysfunction during demand ischemia: rigor underlies increased stiffness without calcium-mediated tension. Amelioration by glycolytic substrate. J Am Coll Cardiol 2001; 37:2144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/73\">",
"      Pepine CJ, Wiener L. Relationship of anginal symptoms to lung mechanics during myocardial ischemia. Circulation 1972; 46:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/74\">",
"      McKenney PA, Apstein CS, Mendes LA, et al. Increased left ventricular diastolic chamber stiffness immediately after coronary artery bypass surgery. J Am Coll Cardiol 1994; 24:1189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/75\">",
"      McKenney PA, Apstein CS, Mendes LA, et al. Immediate effect of aortic valve replacement for aortic stenosis on left ventricular diastolic chamber stiffness. Am J Cardiol 1999; 84:914.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/76\">",
"      Bolli R. Myocardial 'stunning' in man. Circulation 1992; 86:1671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/77\">",
"      Eberli FR, Apstein CS, Ngoy S, Lorell BH. Exacerbation of left ventricular ischemic diastolic dysfunction by pressure-overload hypertrophy. Modification by specific inhibition of cardiac angiotensin converting enzyme. Circ Res 1992; 70:931.",
"     </a>",
"    </li>",
"    <li>",
"     Isoyama S. Interplay of hypertrophy and myocardial ischemia. In: Diastolic Relaxation of the Heart, Lorell BH, Grossman W (Eds), Kluwer Academic Publishers, Boston 1992. p.203.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/79\">",
"      Tomanek RJ, Wessel TJ, Harrison DG. Capillary growth and geometry during long-term hypertension and myocardial hypertrophy in dogs. Am J Physiol 1991; 261:H1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/80\">",
"      Eberli FR, Ritter M, Schwitter J, et al. Coronary reserve in patients with aortic valve disease before and after successful aortic valve replacement. Eur Heart J 1991; 12:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/81\">",
"      Marcus ML, Koyanagi S, Harrison DG, et al. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy. Am J Med 1983; 75:62.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/82\">",
"      Ishihara K, Zile MR, Nagatsu M, et al. Coronary blood flow after the regression of pressure-overload left ventricular hypertrophy. Circ Res 1992; 71:1472.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?15/28/15818/abstract/83\">",
"      MacCarthy PA, Shah AM. Impaired endothelium-dependent regulation of ventricular relaxation in pressure-overload cardiac hypertrophy. Circulation 2000; 101:1854.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3457 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-85.214.214.87-D5DBC4741A-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15818=[""].join("\n");
var outline_f15_28_15818=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13107298\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TERMINOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Systolic versus diastolic HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8876701\">",
"      HFpEF versus diastolic HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Diastolic dysfunction versus DHF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      PHYSIOLOGY OF LEFT VENTRICULAR DIASTOLE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Events during diastole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Normal response to exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      MEASUREMENT OF DIASTOLIC FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Rate of isovolumic relaxation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Rate and extent of LV filling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - E and A waves on Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8876853\">",
"      - E' and A' on myocardial tissue Doppler echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8876861\">",
"      Grades of diastolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Passive elastic stiffness properties",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      ABNORMAL CARDIOVASCULAR STRUCTURE AND FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Structural abnormalities",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Chamber remodeling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Cardiomyocyte and extracellular matrix remodeling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Diastolic dysfunction in DHF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19796955\">",
"      - Exacerbation of diastolic dysfunction during exercise",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Decompensated DHF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Systolic function in DHF",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Dyssynchrony in DHF",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MECHANISMS BY WHICH CARDIAC DISEASES CAUSE DHF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25082686\">",
"      - Two types of ischemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Ischemia and pulmonary symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Reperfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      LV concentric hypertrophy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2111553\">",
"      ASSOCIATION WITH OBSTRUCTIVE SLEEP APNEA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13107298\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/3457\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3457|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/60/18371\" title=\"figure 1\">",
"      Patterns of left ventricular remodeling",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/15/41213\" title=\"figure 2\">",
"      Types of heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/25/20880\" title=\"figure 3\">",
"      LV diastolic pressure and lungs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/59/948\" title=\"figure 4\">",
"      Phases of diastole",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/58/28576\" title=\"figure 5\">",
"      LV filling dynamics HF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/22/17774\" title=\"figure 6\">",
"      LV diastolic pressure volume relationship 1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?12/8/12419\" title=\"figure 7\">",
"      Measures isovolumic relaxation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/33/43538\" title=\"figure 8\">",
"      Abnormal filling pattern",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/32/19982\" title=\"figure 9\">",
"      LV diastolic distensibility - SHF versus DHF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/30/18927\" title=\"figure 10\">",
"      Ambulatory ePAD during progression of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/22/32109\" title=\"figure 11\">",
"      Exercise diastolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/23/33151\" title=\"figure 12\">",
"      Pressure volume exercise",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3457|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?19/7/19580\" title=\"table 1\">",
"      Differential diagnosis of HF-PEF",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/55/10109\" title=\"table 2\">",
"      LV structure and function in chronic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/3457|Waveform\">",
"      <a href=\"#\" title=\"WAVEFORMS\">",
"       WAVEFORMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_waveform\" href=\"UTD.htm?31/45/32470\" title=\"waveform 1\">",
"      Doppler diastolic dysfunction",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/56/18314?source=related_link\">",
"      Cardiac resynchronization therapy in heart failure: Indications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/38/30313?source=related_link\">",
"      Cellular mechanisms of diastolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?17/34/17959?source=related_link\">",
"      Clinical implications and treatment of left ventricular hypertrophy in hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/22/43368?source=related_link\">",
"      Clinical manifestations and diagnosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/42/36522?source=related_link\">",
"      Clinical manifestations, diagnosis, and evaluation of hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/60/33735?source=related_link\">",
"      Echocardiographic evaluation of left ventricular diastolic function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10632?source=related_link\">",
"      Excitation-contraction coupling in myocardium",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/57/28569?source=related_link\">",
"      Heart failure in diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/63/38906?source=related_link\">",
"      Overview of the therapy of heart failure due to systolic dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/50/15144?source=related_link\">",
"      Pathophysiology and clinical presentation of ischemic chest pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/34/23076?source=related_link\">",
"      Pathophysiology of heart failure: Left ventricular pressure-volume relationships",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/40/13956?source=related_link\">",
"      Patient information: Diastolic heart failure (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/54/7018?source=related_link\">",
"      Treatment and prognosis of diastolic heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/59/28600?source=related_link\">",
"      Types and pathophysiology of obstructive hypertrophic cardiomyopathy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f15_28_15819="Causes severe AD";
var content_f15_28_15819=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F66729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F66729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Causes of severe or difficult to treat atopic dermatitis (AD)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Improper diagnosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Treatment failure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Medication used incorrectly",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Treatment regimen is too complex",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Inadequate instructions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Medication not used because of parental or patient fear of medication side effects",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Medication not available",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Due to high cost",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Not on formulary",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist2\">",
"        Not available in the pharmacy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allergic reaction to medication or skin care product (allergic contact dermatitis)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exposure to irritants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Exposure to allergen (food or environmental)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe disease",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15819=[""].join("\n");
var outline_f15_28_15819=null;
var title_f15_28_15820="Antimicrobial prophylaxis lung transplant";
var content_f15_28_15820=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78763&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Standard prophylaxis for bacterial and fungal infections after lung transplantation*",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Bacterial",
"        <span class=\"small\">",
"         &bull;",
"        </span>",
"        :",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ceftazidime: 2 g IV with induction of anesthesia, then 1 g IV every 8 hours for 7 to 10 days.&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vancomycin: 1 g IV with induction of anesthesia, then 1 g IV every 12 hours for 7 to 10 days.&Delta;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Fungal:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Inhaled nebulized amphotericin B lipid complex (ABLC) 50 mg daily for extubated patients and 100 mg daily for intubated patients. Regimen should continue for four days, then weekly while hospitalized.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Nystatin suspension 5 cc swish &amp; swallow four times per day for 6 months post-transplant.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Pneumocystis jirovecii (formerly P. carinii):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Trimethoprim-sulfamethoxazole 1 double-strength tablet orally three times per week starting within one week postoperatively, continuing indefinitely.&Delta;&loz;&sect;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * See appropriate topic reviews for antiviral prophylaxis recommendations.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      The standard regimen should be adjusted as indicated to include coverage for any other known preoperative pathogens in the recipient. This is particularly indicated for recipients with cystic fibrosis, bronchiectasis, and other septic lung diseases. Coverage should also be modified to include for any additional organisms identified from donor bronchial washings.",
"      <br>",
"       &Delta; Doses should be adjusted for renal insufficiency.",
"       <br>",
"        <span class=\"lozenge\">",
"         &loz;",
"        </span>",
"        If sulfa allergic: Atovaquone 1500 mg once daily",
"        <strong>",
"         <em>",
"          or",
"         </em>",
"        </strong>",
"        dapsone 50 mg or 100 mg orally once daily",
"        <strong>",
"         <em>",
"          or",
"         </em>",
"        </strong>",
"        aerosolized pentamidine 300 mg monthly",
"        <strong>",
"         <em>",
"          or",
"         </em>",
"        </strong>",
"        4 mg/kg pentamidine IV monthly, continuing indefinitely.",
"        <br>",
"         &sect; If toxoplasmosis mismatch (donor positive/recipient negative), trimethoprim-sulfamethoxazole should be dosed at 1 double-strength tablet orally once daily.",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15820=[""].join("\n");
var outline_f15_28_15820=null;
var title_f15_28_15821="Rapid overview Epidural hematoma in children";
var content_f15_28_15821=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F69494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F69494&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Rapid overview: Epidural hematoma (EDH) in children",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Head trauma, especially to the temporal region",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Possible signs and symptoms include:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        History of loss of consciousness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        History of altered mental status per caregiver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Severe headache",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Persistent vomiting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Irritability, pallor, cephalohematoma (infants &le;12 months)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lucid interval followed several hours later by clinical deterioration (classic temporal EDH)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Ataxia, dizziness with potential for abrupt catastrophic deterioration (posterior fossa EDH)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Lateralizing signs (anisocoria, hemiparesis, hemiplegia) and Cushing triad (hypertension, bradycardia, respiratory depression) are preterminal findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnostic evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Primary goal is to make the diagnosis of EDH BEFORE neurologic deterioration in an asymptomatic or mildly affected child to allow for timely surgical intervention",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Determine GCS and identify pupillary abnormalities and/or lateralizing motor findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Initial laboratory studies:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Complete blood count with platelets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        PT, PTT, INR",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Type and cross",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Other studies (eg, AST, ALT, and urinalysis) may be indicated in multiple trauma patients",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain emergent unenhanced head CT",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lumbar puncture is contraindicated",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain neurosurgical consultation for all patients with GCS &le;12 or with identified EDH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Manage patient according to principles of advanced trauma life support*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Immobilize cervical spine",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Treat hypoxemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Assess airway, breathing, circulation, and disability and initiate supportive care",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Endotracheally intubate children with GCS &le;8 or rapidly worsening mental status and ventilate to maintain pCO2 between 35 and 40 mmHg",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Provide fluid resuscitation, as needed, to prevent hypotension*",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ensure prompt evaluation by a neurosurgeon to determine need for surgical evacuation of the EDH",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        If signs of herniation, provide hyperosmolar therapy (preferably in consultation with a neurosurgeon):",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        3 percent hypertonic saline solution in a volume of 2 to 6 mL/kg IV per dose (maximum 300 mL), as a rapid bolus infusion. May repeat if needed or initiate infusion. Closely monitor serum sodium concentration and osmolarity (maintain &lt;360 mOsm/L).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        <strong>",
"         OR",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Mannitol 20 percent solution, 0.5 to 1 gram/kg IV per dose, as a rapid bolus infusion. May repeat after 6 hours as needed to increase serum osmolarity (maintain &lt;320 mOsm/L).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Perform mild hyperventilation (PaCO2 30-35 mmHg) for children whose signs of herniation do not respond to mannitol",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     EDH: epidural hematoma; PT: prothrombin time; PTT: partial thromboplastin time; INR: international normalized ratio; AST: aspartate transferase; ALT: alanine transferase; CT: computed tomography; GCS: Glasgow coma scale.",
"     <br/>",
"     * See \"Trauma management: Approach to the unstable child\".",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15821=[""].join("\n");
var outline_f15_28_15821=null;
var title_f15_28_15822="Physical activity with age";
var content_f15_28_15822=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F64352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F64352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 526px\">",
"   <div class=\"ttl\">",
"    Decreased physical activity with age",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 506px; height: 273px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The Surgeon General's report on Physical Activity suggested that the percent of time Americans spend in physical activity decreased as their age increased.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: US Department of Health and Human Services. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, 1996.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15822=[""].join("\n");
var outline_f15_28_15822=null;
var title_f15_28_15823="Congenital syphilis and maternal therapy";
var content_f15_28_15823=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F70059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F70059&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Diagnosis of congenital syphilis (CS) -- United States, 2002",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 500px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention (CDC). Congenital syphilis--United States, 2002. MMWR Morb Mortal Wkly Rep 2004; 53:716.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f15_28_15823=[""].join("\n");
var outline_f15_28_15823=null;
